P.1.f.006 High frequency repetitive TMS over the right dorsolateral prefrontal cortex: influence on Stroop task performance (Englisch)
- Neue Suche nach: Vanderhasselt, M. A.
- Neue Suche nach: De Raedt, R.
- Neue Suche nach: Baeken, C.
- Neue Suche nach: Clerinx, P.
- Neue Suche nach: Leyman, L.
- Neue Suche nach: Dhaenen, H.
- Neue Suche nach: Vanderhasselt, M. A.
- Neue Suche nach: De Raedt, R.
- Neue Suche nach: Baeken, C.
- Neue Suche nach: Clerinx, P.
- Neue Suche nach: Leyman, L.
- Neue Suche nach: Dhaenen, H.
In:
EUROPEAN NEUROPSYCHOPHARMACOLOGY
;
16
;
S276-S277
;
2006
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:P.1.f.006 High frequency repetitive TMS over the right dorsolateral prefrontal cortex: influence on Stroop task performance
-
Beteiligte:Vanderhasselt, M. A. ( Autor:in ) / De Raedt, R. ( Autor:in ) / Baeken, C. ( Autor:in ) / Clerinx, P. ( Autor:in ) / Leyman, L. ( Autor:in ) / Dhaenen, H. ( Autor:in )
-
Erschienen in:EUROPEAN NEUROPSYCHOPHARMACOLOGY ; 16 ; S276-S277
-
Verlag:
- Neue Suche nach: Elsevier Science B.V., Amsterdam.
-
Erscheinungsdatum:01.01.2006
-
Format / Umfang:S276-S277
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 616.8 / 615.1
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
-
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 16
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
The serotonin-1Dβ receptor gene and severity of obsessive-compulsive disorder in women with bulimia nervosaLevitan, R. D. / Kaplan, A. S. / Masellis, M. / Basile, V. S. / Richter, M. A. / Kennedy, J. L. et al. | 2006
- 7
-
UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington's disease and multiple sclerosis, but fails to delay/arrest the progression of different motor-related disordersde Lago, E. / Fernández-Ruiz, J. / Ortega-Gutiérrez, S. / Cabranes, A. / Pryce, G. / Baker, D. / López-Rodríguez, M. / Ramos, J. A. et al. | 2006
- 19
-
Serotonin uptake to lymphocytes of patients with social phobia compared to normal individualsBarkan, T. / Hermesh, H. / Marom, S. / Gurwitz, D. / Weizman, A. / Rehavi, M. et al. | 2006
- 25
-
A hypothalamic endorphinic lesion attenuates acquisition of cocaine self-administration in the ratRoth-Deri, I. / Mayan, R. / Yadid, G. et al. | 2006
- 33
-
Escitalopram versus paroxetine for social anxiety disorder: An analysis of efficacy for different symptom dimensionsStein, D. J. / Andersen, E. W. / Lader, M. et al. | 2006
- 39
-
Effects of chronic treatment with fluvoxamine and paroxetine during adolescence on serotonin-related behavior in adult male ratsde Jong, T. R. / Snaphaan, L. J. / Pattij, T. / Veening, J. G. / Waldinger, M. D. / Cools, A. R. / Olivier, B. et al. | 2006
- 49
-
Plasma serotonin levels and suicidal behavior in adolescentsTyano, S. / Zalsman, G. / Ofek, H. / Blum, I. / Apter, A. / Wolovik, L. / Sher, L. / Sommerfeld, E. / Harell, D. / Weizman, A. et al. | 2006
- 59
-
Cognitive evaluation of disease-modifying efficacy of Galantamine and Memantine in the APP23 modelVan Dam, D. / De Deyn, P. P. et al. | 2006
- 71
-
Bipolar mania and plasma amino acids: Increased levels of glycineHoekstra, R. / Fekkes, D. / Loonen, A. J. / Pepplinkhuizen, L. / Tuinier, S. / Verhoeven, W. M. et al. | 2006
- 79
-
Antidepressants use in children and adolescents and the risk of suicideWohlfarth, T. D. / van Zwieten, B. J. / Lekkerkerker, F. J. / Gispen-de Wied, C. C. / Ruis, J. R. / Elferink, A. J. / Storosum, J. G. et al. | 2006
- 85
-
Protective effect of vineatrol against kainic acid induced seizures, oxidative stress and on the expression of heat shock proteins in ratsGupta, Y. K. / Briyal, S. et al. | 2006
- 93
-
Placebo-controlled trial of agomelatine in the treatment of major depressive disorderKennedy, S. H. / Emsley, R. et al. | 2006
- 101
-
Effect of vitamin E on memory retention in rats: Possible involvement of cholinergic systemEidi, A. / Eidi, M. / Mahmoodi, G. / Oryan, S. et al. | 2006
- 107
-
Red cell membrane omega-3 fatty acids are decreased in nondepressed patients with social anxiety disorderGreen, P. / Hermesh, H. / Monselise, A. / Marom, S. / Presburger, G. / Weizman, A. et al. | 2006
- 115
-
Sex-dependent effects of fluoxetine and triiodothyronine in the forced swim test in ratsLifschytz, T. / Shalom, G. / Lerer, B. / Newman, M. E. et al. | 2006
- 123
-
Genetic polymorphisms of alcohol and aldehyde dehydrogenase, dopamine and serotonin transporters in familial and non-familial alcoholismChoi, I. G. / Kee, B. S. / Son, H. G. / Ham, B. J. / Yang, B. H. / Kim, S. H. / Lee, J. S. / Son, B. K. / Lee, B. Y. / Lee, S. Y. et al. | 2006
- 129
-
Combination of adenosine A1 and A2A receptor blocking agents induces caffeine-like locomotor stimulation in miceKuzmin, A. / Johansson, B. r. / Gimenez, L. / Ögren, S. O. / Fredholm, B. B. et al. | 2006
- 137
-
Alterations in DHEA metabolism in schizophrenia: Two-month case-control studyRitsner, M. / Gibel, A. / Ram, E. / Maayan, R. / Weizman, A. et al. | 2006
- 147
-
Effects of α-phenyl-N-tert-butyl nitrone and N-acetylcysteine on hydroxyl radical formation and dopamine depletion in the rat striatum produced by d-amphetamineWan, F. J. / Tung, C. S. / Shiah, I. S. / Lin, H. C. et al. | 2006
- 155
-
The relevance of neurosteroids to clinical psychiatry: From the laboratory to the bedsideStrous, R. D. / Maayan, R. / Weizman, A. et al. | 2006
- 170
-
Potent protection of ferulic acid against excitotoxic effects of maternal intragastric administration of monosodium glutamate at a late stage of pregnancy on developing mouse fetal brainYu, L. / Zhang, Y. / Ma, R. / Bao, L. / Fang, J. / Yu, T. et al. | 2006
- 178
-
The effect of tricyclic antidepressants, selective serotonin reuptake inhibitors (SSRIs) and newer antidepressant drugs on the activity and level of rat CYP3AHaduch, A. / Wójcikowski, J. / Daniel, W. A. et al. | 2006
- 187
-
Prevalence of diabetes mellitus in chronic schizophrenic inpatients in relation to long-term antipsychotic treatmentCohen, D. / Dekker, J. J. / Peen, J. / Gispen-de Wied, C. C. et al. | 2006
- 195
-
Dopaminergic drugs may counteract behavioral and biochemical changes induced by models of brain injuryMicale, V. / Incognito, T. / Ignoto, A. / Rampello, L. / Spartà, M. / Drago, F. et al. | 2006
- 204
-
Caffeine modulates P50 auditory sensory gating in healthy subjectsGhisolfi, E. S. / Schuch, A. / Strimitzer, I. M. / Luersen, G. / Martins, F. o. / Ramos, F. L. / Becker, J. / Lara, D. R. et al. | 2006
- 211
-
Distinct gene expression profiles in adult rat brains after acute MK-801 and cocaine treatmentsStorvik, M. / Tiikkainen, P. / van Iersel, M. / Wong, G. et al. | 2006
- 220
-
α-[11C]Methyl-l-tryptophan trapping in the orbital and ventral medial prefrontal cortex of suicide attemptersLeyton, M. / Paquette, V. / Gravel, P. / Rosa-Neto, P. / Weston, F. / Diksic, M. / Benkelfat, C. et al. | 2006
- 224
-
ECNP consensus meeting March 2003 guidelines for the investigation of efficacy in substance use disordersVan den Brink, W. / Montgomery, S. A. / Van Ree, J. M. / van Zwieten-Boot, B. J. et al. | 2006
- 233
-
Plasma antipsychotic concentration and receptor occupancy, with special focus on risperidone long-acting injectableMedori, R. / Mannaert, E. / Gründer, G. et al. | 2006
- 241
-
Hypofunction of the dorsal hippocampal NMDA receptors impairs retrieval of memory to partially presented foreground context in a single-trial fear conditioning in ratsMelik, E. / Babar, E. / Ozen, E. / Ozgunen, T. et al. | 2006
- 248
-
Dopamine D2 receptor gene variants and quantitative measures of positive and negative symptom response following clozapine treatmentHwang, R. / Shinkai, T. / Deluca, V. / Macciardi, F. / Potkin, S. / Meltzer, H. Y. / Kennedy, J. L. et al. | 2006
- 260
-
Immobilization stress causes extra-cellular oxidant–antioxidant imbalance in rats: Restoration by L-NAME and vitamin ENadeem, A. / Masood, A. / Masood, N. / Gilani, R. A. / Shah, Z. A. et al. | 2006
- 268
-
Association study between the novel functional polymorphism of the serotonin transporter gene and suicidal behaviour in schizophreniaDe Luca, V. / Zai, G. / Tharmalingam, S. / de Bartolomeis, A. / Wong, G. / Kennedy, J. L. et al. | 2006
- 272
-
Allopregnanolone produces hyperphagia by reducing neophobia without altering food palatabilityFudge, M. A. / Kavaliers, M. / Ossenkopp, K. P. et al. | 2006
- 281
-
A double-blind, randomised, controlled clinical trial of acetyl-l-carnitine vs. amisulpride in the treatment of dysthymiaZanardi, R. / Smeraldi, E. et al. | 2006
- 288
-
Activation of pyramidal cells in rat medial prefrontal cortex projecting to ventral tegmental area by a 5-HT1A receptor agonistDíaz-Mataix, L. / Artigas, F. / Celada, P. et al. | 2006
- 297
-
Effect of 5-HT3 receptor antagonist MDL 72222 on behaviors induced by ketamine in rats and miceKos, T. / Popik, P. / Pietraszek, M. / Schäfer, D. / Danysz, W. / Dravolina, O. / Blokhina, E. / Galankin, T. / Bespalov, A. Y. et al. | 2006
- 311
-
A systematic review of the effectiveness of naltrexone in the maintenance treatment of opioid and alcohol dependenceRoozen, H. G. / de Waart, R. / van der Windt, D. A. / van den Brink, W. / de Jong, C. A. / Kerkhof, A. J. et al. | 2006
- 324
-
Antidepressant-like effect of harmane and other β-carbolines in the mouse forced swim testFarzin, D. / Mansouri, N. et al. | 2006
- 329
-
Dehydroepiandrosterone (DHEA) attenuates cocaine-seeking behavior in the self-administration model in ratsMaayan, R. / Lotan, S. / Doron, R. / Shabat-Simon, M. / Gispan-Herman, I. / Weizman, A. / Yadid, G. et al. | 2006
- 340
-
Fluoxetine in the acute treatment and relapse prevention of combat-related post-traumatic stress disorder: Analysis of the veteran group of a placebo-controlled, randomized clinical trialMartenyi, F. / Soldatenkova, V. et al. | 2006
- 350
-
PET neuroimaging of [11C]mirtazapine enantiomers in pigsSmith, D. F. / Marthi, K. / Munk, O. L. / Cumming, P. / Hansen, S. r. / Jakobsen, S. et al. | 2006
- 358
-
Cerebral metabolic consequences in the adult brain after neonatal excitotoxic lesions of the amygdala in ratsGerrits, M. A. / Wolterink, G. / van Ree, J. M. et al. | 2006
- 366
-
Diabetes mellitus and antipsychotic treatment in the United KingdomCarlson, C. / Hornbuckle, K. / DeLisle, F. / Kryzhanovskaya, L. / Breier, A. / Cavazzoni, P. et al. | 2006
- 376
-
The pharmacokinetics and pharmacodynamics of tandospirone in rats exposed to conditioned fear stressNishitsuji, K. / To, H. / Shimizu, T. / Yanase, Y. / Yamada, T. / Hara, C. / Mine, K. / Higuchi, S. et al. | 2006
- 383
-
Imipramine treatment ameliorates corticosterone-induced alterations in the effects of 5-HT1A and 5-HT4 receptor activation in the CA1 area of rat hippocampusZahorodna, A. / Tokarski, K. / Hess, G. et al. | 2006
- 391
-
Dopaminergic-based pharmacotherapies for depressionPapakostas, G. I. et al. | 2006
- 403
-
AgRP(83–132) and SHU9119 differently affect activity-based anorexiaHillebrand, J. J. / Kas, M. J. / Scheurink, A. J. / van Dijk, G. / Adan, R. A. et al. | 2006
- 413
-
Increased use of mental health services related to Isotretinoin treatment: A 5-year analysisFriedman, T. / Wohl, Y. / Knobler, H. Y. / Lubin, G. / Brenner, S. / Levi, Y. / Barak, Y. et al. | 2006
- 417
-
Effects of melatonin and agomelatine in anxiety-related procedures in rats: Interaction with diazepamLoiseau, F. / Le Bihan, C. / Hamon, M. / Thiébot, M. H. et al. | 2006
- 429
-
Characterization of the serotonin transporter in lymphocytes and platelets of schizophrenia patients treated with atypical or typical antipsychotics compared to healthy individualsBarkan, T. / Peled, A. / Modai, I. / Weizman, A. / Rehavi, M. et al. | 2006
- 437
-
Disruption of orofacial movement topographies in congenic mutants with dopamine D5 but not D4 receptor or DARPP-32 transduction ‘knockout’Tomiyama, K. / Makihara, Y. / Yamamoto, H. / O'Sullivan, G. / Nally, R. E. / Tighe, O. / Kinsella, A. / Fienberg, A. A. / Grandy, D. K. / Sibley, D. R. et al. | 2006
- 446
-
Association between the dopamine D2 receptor TaqI A2 allele and low activity COMT allele with obsessive–compulsive disorder in malesDenys, D. / Van Nieuwerburgh, F. / Deforce, D. / Westenberg, H. et al. | 2006
- 451
-
Dual monoamine modulation for the antidepressant-like effect of lamotrigine in the modified forced swimming testConsoni, F. T. / Vital, M. A. / Andreatini, R. et al. | 2006
- 459
-
Diminished neurocardiac dynamics associated with antipsychotic-induced extrapyramidal syndromeKim, J. H. / Yi, S. H. / Park, K. T. / Ahn, Y. M. / Lee, K. Y. / Yang, S. A. / Kim, Y. S. et al. | 2006
- 464
-
From selective to highly selective SSRIs: A comparison of the antinociceptive properties of fluoxetine, fluvoxamine, citalopram and escitalopramSchreiber, S. / Pick, C. G. et al. | 2006
- 469
-
Schizophrenia-associated neural growth factors in peripheral blood. A reviewvan Beveren, N. J. / van der Spelt, J. J. / de Haan, L. / Fekkes, D. et al. | 2006
- 481
-
Antidepressants suppress production of the Th1 cytokine interferon-γ, independent of monoamine transporter blockadeDiamond, M. / Kelly, J. P. / Connor, T. J. et al. | 2006
- 491
-
Role of nigral NFκB p50 and p65 subunit expression in haloperidol-induced neurotoxicity and stereotyped behavior in ratsSaldaña, M. / Bonastre, M. / Aguilar, E. / Marin, C. et al. | 2006
- 498
-
Association study of two serotonin 1A receptor gene polymorphisms and fluoxetine treatment response in Chinese major depressive disordersYu, Y. W. / Tsai, S. J. / Liou, Y. J. / Hong, C. J. / Chen, T. J. et al. | 2006
- 504
-
Anxiety and ethanol consumption in victorious and defeated mice; effect of κ-opioid receptor activationKudryavtseva, N. / Gerrits, M. A. / Avgustinovich, D. F. / Tenditnik, M. V. / Van Ree, J. M. et al. | 2006
- 512
-
Lack of effect of acute dopamine precursor depletion in nicotine-dependent smokersCasey, K. F. / Benkelfat, C. / Young, S. N. / Leyton, M. et al. | 2006
- 521
-
Proteomic analysis of rat hippocampus and frontal cortex after chronic treatment with fluoxetine or putative novel antidepressants: CRF1 and NK1 receptor antagonistsCarboni, L. / Vighini, M. / Piubelli, C. / Castelletti, L. / Milli, A. / Domenici, E. et al. | 2006
- 538
-
Melatonin affects the immobility time of rats in the forced swim test: The role of serotonin neurotransmissionMicale, V. / Arezzi, A. / Rampello, L. / Drago, F. et al. | 2006
- 546
-
ECNP 2007 Award for outstanding scientists| 2006
- 547
-
Faulty regulation of tau phosphorylation by the reelin signal transduction pathway is a potential mechanism of pathogenesis and therapeutic target in Alzheimer's diseaseDeutsch, S. I. / Rosse, R. B. / Deutsch, L. H. et al. | 2006
- 552
-
Visualization of the cortical dopamine transporter in type 1 and 2 alcoholics with human whole hemisphere autoradiographyTupala, E. / Halonen, P. / Tiihonen, J. et al. | 2006
- 561
-
Chronic fluoxetine upregulates arachidonic acid incorporation into the brain of unanesthetized ratsQu, Y. / Chang, L. / Klaff, J. / Seemann, R. / Greenstein, D. / Rapoport, S. I. et al. | 2006
- 572
-
Serotonin transporter characteristics in lymphocytes and platelets of male aggressive schizophrenia patients compared to non-aggressive schizophrenia patientsBarkan, T. / Peled, A. / Modai, I. / Barak, P. / Weizman, A. / Rehavi, M. et al. | 2006
- 580
-
Direct and indirect interactions between antidepressant drugs and CYP2C6 in the rat liver during long-term treatmentDaniel, W. A. / Haduch, A. / Syrek, M. / Boksa, J. et al. | 2006
- 588
-
Homocysteine levels in adolescent schizophrenia patientsNevo, G. A. / Meged, S. / Sela, B. A. / Hanoch-Levi, A. / Hershko, R. / Weizman, A. et al. | 2006
- 592
-
Effects of acute and subchronic d-amphetamine on ventral striatal concentrations of neurotensin and neuropeptide Y in rats treated with antipsychotic drugsGruber, S. H. / Nomikos, G. G. / Mathé, A. A. et al. | 2006
- 601
-
The Montgomery Äsberg and the Hamilton ratings of depression: A comparison of measuresCarmody, T. J. / Rush, A. J. / Bernstein, I. / Warden, D. / Brannan, S. / Burnham, D. / Woo, A. / Trivedi, M. H. et al. | 2006
- 612
-
GABAA receptor modulation of 5-HT neuronal firing in the median raphe nucleus: Implications for the action of anxiolyticsJudge, S. J. / Young, R. L. / Gartside, S. E. et al. | 2006
- 620
-
Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patientsBocchio-Chiavetto, L. / Zanardini, R. / Bortolomasi, M. / Abate, M. / Segala, M. / Giacopuzzi, M. / Riva, M. A. / Marchina, E. / Pasqualetti, P. / Perez, J. et al. | 2006
- 625
-
Author Index (Volume 16)| 2006
- 631
-
Key Word Index (Volume 16)| 2006
- 643
-
Contents of Volume 16 (2006)| 2006
- I
-
Announcement| 2006
- S1
-
Using mutational studies to determine the role of neurotransmitters in developmentLesch, K. P. et al. | 2006
- S3
-
Impact of prenatal dexamethasone on proliferation, migration and survival of cortical cellsPrzyborowska, A. / Fijal, K. / Wedzony, K. et al. | 2006
- S4
-
Fluorescence in vitro studies of human dopamine d1 and d2 receptor proteins interactionFaron-Gorecka, A. / Andrecka, J. / Dziedzicka-Wasylewska, M. / Wasylewski, Z. et al. | 2006
- S6
-
Combination of deferoxamine and lamotrigine in a rat model of hypoxic-ischemic brain damagePapazisis, G. / Kouvelas, D. / Kallaras, K. / Kaiki-Astara, A. / Guiba-Tziampiri, O. et al. | 2006
- S7
-
Correlations between serum orexins A and B and ghrelin and BMI in anorexia nervosaJanas-Kozik, M. / Krupka-Matuszczyk, I. / Krzystanek, M. et al. | 2006
- S8
-
Effect of repeated cocaine administration on the mRNAs expression of main classes of G alpha proteins in the rat brainZelek-Molik, A. / Kreiner, G. / Roman, A. / Bielawski, A. / Nalepa, I. et al. | 2006
- S10
-
Differential accumulation of cortisol and corticosterone in the murine brainMason, B. / Pariante, C. M. / Sanderson, L. / Thomas, S. A. et al. | 2006
- S11
-
GABAB receptor positive modulation attenuates selected molecular markers relevant to cocaine and nicotine dependenceLhuillier, L. / Mombereau, C. / Cryan, J. F. / Kaupmann, K. et al. | 2006
- S12
-
Identification and functional assessment of small peptides antagonists of brain-derived neurotrophic factor (BDNF)Cazorla, M. / Rose, C. / Pilon, C. / Arrang, J. M. / Sokoloff, P. et al. | 2006
- S13
-
Lithium effects on basal and stimulated CREB phosphorylation in SH-SY5Y cells: a bimodal action on CaMKIV and Erk1/2Tardito, D. / Pelizzoni, I. / Soncin, A. / Kasahara, J. / Racagni, G. / Popoli, M. et al. | 2006
- S14
-
Neural stem cell proliferation is significantly reduced in schizophrenia, but not in depression or bipolar disorderFritzen, S. / Strobel, A. / Schmitt, A. / Lesch, K. P. / Reif, A. et al. | 2006
- S15
-
Possible convergence of norepinephrine and glucocorticoids signaling pathways: relevance to depression and its treatmentYaniv, S. P. / Ben-Shachar, D. / Klein, E. et al. | 2006
- S16
-
Potential molecular interactions between the histamine H3 receptor and the dopamine D2 receptor in the rat striatumHumbert-Claude, M. / Morisset, S. / Gbahou, F. / Arrang, J. M. et al. | 2006
- S18
-
Vagus nerve stimulation increases neurotrophins gene expression and alters cell proliferation in the rat hippocampusFollesa, P. / Biggio, F. / Caria, S. / Gorini, G. / Marrosu, F. / Biggio, G. et al. | 2006
- S19
-
Biomarker discovery in cerebrospinal fluid of depressed patientsDitzen, C. / Tang, N. / Jacob, A. / Uhr, M. / Miller, C. / Turck, C. W. et al. | 2006
- S20
-
Functional proteomic analysis of an animal model of depression combining genetic vulnerability and environmental stressMallei, A. / Giambelli, R. / Barbiero, V. S. / Maglione, M. / Mathè / A. A. / El Khoury, A. / Carboni, L. / Domenici, E. / Racagni, G. et al. | 2006
- S21
-
Polymorphic variants in the transcriptional control region of TPH2 are preferentially transmitted in ADHDRenner, T. / Walitza, S. / Dempfle, A. / Konrad, K. / Wewetzer, C. / Halbach, A. / Herpertz-Dahlmann, B. / Remschmidt, H. / Smidt, J. / Linder, M. et al. | 2006
- S22
-
Analysis of prolyl oligopeptidase (PO) as a target for bipolar disorder — characterisation of PO null-mutant miceDi Daniel, E. / Mudge, A. S. / Maycox, P. R. et al. | 2006
- S24
-
Glucocorticoid sensitivity in whole blood cells from healthy volunteers: effect of antidepressantsOarvalho, L. / Juruena, M. F. / Papadopoulos, A. / Poon, L. / Kerwin, R. / Pariante, C. M. et al. | 2006
- S25
-
MDMA (“ECSTASY”) suppresses innate IFN-gamma production and signalling, and inhibits MHC II expression on APCsBoyle, N. T. / Connor, T. J. et al. | 2006
- S26
-
Molecular mechanisms of cannabinoid-induced neurotoxicity in rat cortical neuronsGowran, A. M. / Campbell, V. A. et al. | 2006
- S27
-
Noradrenaline stimulates production of interleukin-1 receptor antagonist in glial cells in via B2-adrenoceptor activationMcNamee, E. N. / Connor, T. J. et al. | 2006
- S28
-
Hypothalamic-pituitary-adrenocortical axis changes in male Sprague-Dawley rats after long-term voluntary exerciseDroste, S. K. / Chandramohan, Y. / Reul, J. M. et al. | 2006
- S29
-
Augmentation of antidepressant response by atypical antipsychotic drugs: electrophysiological studies in the rat brainDremencov, E. / El Mansari, M. / Blier, P. et al. | 2006
- S30
-
Inhibition of glycine uptake augments risperidone's effect on prefrontal glutamatergic transmissionKonradsson, A. / Marcus, M. M. / Hertel, P. / Svensson, T. H. / Jardemark, K. E. et al. | 2006
- S31
-
Potentiating antidepressant strategy: focus on NK1 receptor antagonistsGuiard, B. P. / Gardier, A. M. / Blier, P. et al. | 2006
- S33
-
Effects of acute stress on brain-derived neurotrophic factor in the hippocampus of transgenic mouse model of depressionAlboni, S. / Blom, J. M. / Corsini, D. / Benatti, C. / Capone, G. / Ferraguti, C. / Barden, N. / Tascedda, F. / Brunello, N. et al. | 2006
- S34
-
Allosteric changes of the NMDA receptor trap diffusible dopamine 1 receptors in spinesScott, L. / Zelenin, S. / Malmersjö / S. / Kowalewski, J. M. / Zettergren-Markus, E. / Nairn, A. C. / Greengard, P. / Brismar, H. / Aperia, A. et al. | 2006
- S35
-
Genetic association data from GENDEP, a multicentre European studyHuezo-Diaz, P. / Nash, M. / Hoda, F. / Williamson, R. / McGuffin, P. / Craig, I. / Aitchison, K. J. et al. | 2006
- S37
-
Animal models of human behaviour: can they help in understanding pathology and in drug development?Rodgers, R. J. et al. | 2006
- S39
-
Long lasting effects of anti-depressants on olfactory bulbectomy induced hyperactivity in the open fieldBreuer, M. E. / Groenink, L. / Oosting, R. S. / Olivier, B. et al. | 2006
- S40
-
Strain differences in the effects of GABAA receptor subtype selective compounds in the mouse light-dark testMathiasen, L. / Mirza, N. R. / Rodgers, R. J. et al. | 2006
- S41
-
Comparative effects of PYY3–36, CCK-8S and sibutramine on food intake, feeding behaviour and weight gain in ratsHolch, P. / Rodgers, R. J. et al. | 2006
- S42
-
Behavioral and biochemical effects of single dose of desipramine are time-dependentKusmider, M. / Faron-Gorecka, A. / Dziedzicka-Wasylewska, M. et al. | 2006
- S43
-
Search for the pharmacotherapy of nicotine addiction: focus on the nicotinic receptor subtypes and cannabinoid systemZaniewska, M. / McCreary, A. C. / Filip, M. / Przegaliń / ski, E. et al. | 2006
- S45
-
On the role of serotonin 1B (5-HT1B) receptors in cocaine- or food-maintained behaviour in ratsGolda, A. / Filip, M. / Przegaliń / ski, E. et al. | 2006
- S46
-
Clozapine application in prefrontal cortex blocks the effects of systemic MK-801 on extracellular 5-HT and glutamateLó / pez-Gil, X. / Babot, Z. / Amargó / s-Bosch, M. / Suñ / ol, C. / Artigas, F. / Adell, A. et al. | 2006
- S47
-
Depression co-morbid with Alzheimer's disease: the role of stress factorsPonomareva, E. et al. | 2006
- S48
-
Effects of T3 and fluoxetine in the novelty-suppressed feeding test model of depression and anxiety: gender differencesShalom, G. / Lifschytz, T. / Lerer, B. / Newman, M. E. et al. | 2006
- S49
-
Cannabinoid modulation of impulsivity in rats: a novel pharmacotherapeutic approach for inhibitory control deficits?Pattij, T. / Janssen, M. C. / Schepers, I. / Gonzalez Cuevas, G. / Schoffelmeer, A. N. et al. | 2006
- S50
-
Increased activity of prefrontal pyramidal neurons after phencyclidine administration: reversal by clozapineKargieman, L. / Celada, P. / Artigas, F. et al. | 2006
- S51
-
Studying the neural changes underlying the transition from casual to compulsive drug useRijkens, M. M. / Vanderschuren, L. J. et al. | 2006
- S53
-
The anxiolytic effect of CRF in rat brain frontal cortex is prevented by CRF1&2 receptor antagonistsZieba, B. / Uchacz, T. / Domin, H. / Branski, P. / Smialowska, M. / Pilc, A. et al. | 2006
- S54
-
Abnormal social cognitive processing in 47, XXY men: implications for the study of schizophreniavan Rijn, S. / Swaab, H. / Aleman, A. / Jellema, T. / Kahn, R. S. et al. | 2006
- S55
-
Cannabinoid CB1 receptor blocakade affects memory capacity of dopamine D3 KO mice pre-treated with β-amyloid peptideMazzola, C. / Micale, V. / Leggio, G. M. / Drago, F. et al. | 2006
- S56
-
Effect of lithium on the deficit in performance of a reversal learning task induced by phencyclidine in the ratIdris, N. / Grayson, B. / Neill, J. C. et al. | 2006
- S58
-
The effect of neurotrophin receptor expression and signalling on recognition learning in the ratHennigan, A. / Kelly, A. et al. | 2006
- S59
-
Age and strain-related differences in sensory-motor abilities in different mouse strainsDeiana, S. / Harrington, C. / Riedel, G. et al. | 2006
- S61
-
Behavioral effects of SR 58611A, a beta-3 agonist, on experimental models of mild stressLeggio, G. M. / Micale, V. / Consoli, D. / Mazzola, C. / Drago, F. et al. | 2006
- S62
-
The role of medial septal NMDA receptors in behavioral functions of the hippocampus in the ratElvander Tottie, E. / Eriksson, T. / Johansson, B. / Sandin, J. / gren, S. O. et al. | 2006
- S65
-
The pre-synaptic dopaminergic system before and after the onset of psychosis: initial resultsHowes, O. D. / Montgomery, S. A. / Asselin, M. / Murray, R. M. / McGuire, P. K. / Grasby, P. et al. | 2006
- S66
-
Changes in benzodiazepine receptor binding in Dutch veterans with posttraumatic stress disorderGeuze, E. / van Berckel, B. N. / Boellaard, R. / Windhorst, B. D. / Luurtsema, G. / Lammertsma, A. A. / Vermetten, E. / Westenberg, H. G. et al. | 2006
- S67
-
Association study of a functional cathechol-O-methyltransferase polymorphism and cognitive remediation in schizophreniaBosia, M. / Cavallaro, R. / Anselmetti, S. / Bechi, M. / Cocchi, F. / Poletti, S. / Marino, E. et al. | 2006
- S68
-
Cannabis use increases body mass index in patients with psychosisMondelli, V. / Di Forti, M. / Saeedzadeh-Sardahaee, F. / Butt, A. / Miorelli, A. / Mule, A. / Gafoor, R. / Dazzan, P. / Murray, R. M. / Pariante, C. M. et al. | 2006
- S70
-
Influence of serotonin transporter promoter polymorphism on brain activation during a moral valence decision taskRadaelli, D. / Bernasconi, A. / Benedetti, F. / Blasi, V. / Colombo, C. / Falini, A. / Scotti, G. / Smeraldi, E. et al. | 2006
- S71
-
Is controversial efficacy of SSRI in treating depression in child and adolescent related to differences in study design?Usala, T. / Clavenna, A. / Bonati, M. / Zuddas, A. et al. | 2006
- S72
-
Long term outcome of drug-resistant bipolar depression: a 9 months prospective follow-up after chronotherapeuticsPontiggia, A. / Benedetti, F. / Barbini, B. / Cigala Fulgosi, M. / Colombo, C. / Dallaspezia, S. / Smeraldi, E. et al. | 2006
- S73
-
Predictive parameters for methylphenidate use and compliance in children with attention deficit hyperactivity disorderAtzori, P. / Ancilletta, B. / Usala, T. / Danjou, F. / Zuddas, A. et al. | 2006
- S74
-
Divalproex sodium vs. placebo for the treatment of child and adolescent autismAnagnostou, E. / Soorya, L. / Swanson, E. / Rusoff, J. / Chaplin, W. / Wasserman, S. / Hollander, E. et al. | 2006
- S78
-
Progressive brain volume changes in first-episode psychosis: a five-year follow-up studyRais, M. / Cahn, W. / van Haren, N. E. / Hulshoff Pol, H. E. / Caspers, E. / Schnack, H. G. / Kahn, R. S. et al. | 2006
- S79
-
Single or low dose of ecstasy, is it safe? A prospective study on neurotoxicity of ecstasy in new ecstasy usersde Win, M. M. / Jager, G. / Reneman, L. / Lavini, C. / van den Brink, W. / den Heeten, G. J. et al. | 2006
- S80
-
Specific effects of ecstasy on memory: a new approach to investigate neurotoxic effects in poly-substance ecstasy usersJager, G. / de Win, M. M. / van der Tweel, I. / Kahn, R. S. / van Ree, J. M. / van den Brink, W. / Ramsey, N. F. et al. | 2006
- S81
-
The effects of exertion and high levels of lactate in a 35% CO2 challenge in patients with panic disorderEsquivel, G. / Berlanga-Cisneros, C. / Lara-Muñ / oz, C. / Griez, E. et al. | 2006
- S82
-
An open-label trial of escitalopram in the treatment of impulsive-compulsive internet usage disorderDell' Osso, B. / Altamura, A. C. / Hadley, S. J. / Baker, B. R. / Hollander, E. et al. | 2006
- S86
-
Anxiolytic-like effects of group III mGluR positive modulator PHCCC and agonist ACPT-I injected to the rat hippocampusStachowicz, K. / Chojnacka-Wó / jcik, E. / Klak, K. / Pilc, A. et al. | 2006
- S87
-
Benzodiazepines vs. combination of benzodiazepines and SSRI in treatment of panic disorder with agoraphobiaLatas, M. et al. | 2006
- S89
-
Anxiolytic and antidepressant-like activities of UFP-512, a novel selective delta opioid receptor agonistVergura, R. / Balboni, G. / Spagnolo, B. / Gavioli, E. C. / Lambert, D. G. / McDonald, J. / Trapella, C. / Regoli, D. / Salvadori, S. / Calo, G. et al. | 2006
- S90
-
In search of the anxiolytic effects of nicotinic receptor ligandsKrawczyk, M. / Popik, P. et al. | 2006
- S91
-
Molecular dissection of the role of GABAB1 receptor isoforms 1a and 1b in anxiety-related behaviourJacobson, L. H. / Neijt, H. C. / Bettler, B. / Kaupmann, K. / Cryan, J. F. et al. | 2006
- S92
-
Anxiety as a consequence of hypokinesia and its correction by afobazoleAshrafyan, K. / Balasanyan, M. et al. | 2006
- S95
-
Author index| 2006
- S99
-
Keyword index| 2006
- S101
-
Generalized anxiety disorder: What are we missing?Allgulander, C. et al. | 2006
- S109
-
Generalized anxiety disorder: A comorbid diseaseNutt, D. / Argyropoulos, S. / Hood, S. / Potokar, J. et al. | 2006
- S119
-
Therapeutic options: Addressing the current dilemmaDinan, T. et al. | 2006
- S128
-
Pregabalin: From molecule to medicineKavoussi, R. et al. | 2006
- S135
-
Optimisation of long-term treatment in schizophrenia: Treating the true spectrum of symptomsKasper, S. et al. | 2006
- S142
-
Long-term health considerations in schizophrenia: Metabolic effects and the role of abdominal adiposityVan Gaal, L. F. et al. | 2006
- S149
-
Differential metabolic effects of antipsychotic treatmentsHaupt, D. W. et al. | 2006
- S156
-
Meeting everyday challenges: Antipsychotic therapy in the real worldGorwood, P. et al. | 2006
- S165
-
S.01.04 Psycho-education in management of schizophreniaHoschl1, C. / Motlova, L. et al. | 2006
- S166
-
S.02.02 Abnormal development of brain function in ADHD and effects of methylphenidateRubia, K. / Halari, R. / Smith, A. B. / Mohammad, M. / Taylor, E. et al. | 2006
- S167
-
S.02.05 Neurocognitive effects of methylphenidate in adult attention deficit/hyperactivity disorderBekker, E. M. / Verster, J. C. / Kenemans, J. L. et al. | 2006
- S168
-
S.03.03 mRNA expression in post-mortem studiesGarcia-Sevilla, J. A. / Arteta, D. / Meana, J. J. et al. | 2006
- S169
-
S.04.01 Functional proteomic analysis of an animal model of depression combining genetic vulnerability and environmental stressMallei, A. / Giambelli, R. / Barbiero, V. S. / Mathe, A. A. / El Khoury, A. / Carboni, L. / Domenici, E. / Aitchison, K. J. / Racagni, G. / Popoli, M. et al. | 2006
- S170
-
S.04.04 Abnormalities in behaviour and reduction in expression of specific hippocampal genes genes by prenatal stress in female offspring are reversed by neonatal handlingNachum-Biala, Y. / Salomon, S. / Bogosh, Y. / Linial, M. / Weinstock, M. et al. | 2006
- S171
-
S.04.06 Fluorescence in vitro studies of human dopamine D1 and D2 receptor proteins interactionFaron-Gorecka, A. / Andrecka, J. / Dziedzicka-Wasylewska, M. / Wasylewski, Z. et al. | 2006
- S173
-
S.05.04 Steroid hormone treatmentsWolkowitz, O. M. / Reus, V. I. / Epel, E. / Mellon, S. et al. | 2006
- S175
-
S.07.03 RIC-3, an effector of nAChR activity: structure, function, quantity, and regulationBiala, Y. / Treinin, M. et al. | 2006
- S176
-
S.07.06 Specific effects of ecstasy on memory: a new approach to investigate neurotoxic effects in poly-substance ecstasy usersJager, G. / De Win, M. M. / Kahn, R. S. / Van Ree, J. M. / Van den Brink, W. / Ramsey, N. F. et al. | 2006
- S177
-
S.07.08 Is controversial efficacy of SSRI in treating depression in child and adolescent related to differences in study design?Usala, T. / Clavenna, A. / Bonati, M. / Zuddas, A. et al. | 2006
- S178
-
S.08.03 D2 antagonist/5-HT1A agonist interactionsNewman-Tancredi, A. et al. | 2006
- S179
-
S.09.01 Bipolar spectrum disorder: relapse and remissionJudd, L. et al. | 2006
- S180
-
S.09.04 New antiepileptics in bipolar mixed statesPerugi, G. et al. | 2006
- S181
-
S.10.03 Neuroimaging .ndings in pathological gamblingBuchel, C. et al. | 2006
- S182
-
S.11.01 Common pathological pathways in neurodegenerative brain diseases: the genes involved in Parkinsons diseaseBrice, A. et al. | 2006
- S183
-
S.11.05 Growth factors in the treatment of neurodegenerative diseasesSaarma, M. et al. | 2006
- S184
-
S.14.04 CATIE trial resultsLieberman, J. A. / Stroup, T. S. / McEvoy, J. P. / Swartz, M. S. / Keefe, R. / Perkins, D. O. / Davis, S. / Davis, C. E. / Lebowitz, B. / Hsiao, J. et al. | 2006
- S187
-
S.16.03 Chronic fatigue syndromeKerr, J. R. / Petty, R. / Burke, B. / Fear, D. / Montgomery, J. / Richards, S. C. / Thomas, M. / Smith, A. P. / Harrison, T. J. / Kellam, P. et al. | 2006
- S188
-
S.17.01 Pharmacological management of .rst episode adolescent psychosisFegert, J. / Libal, G. / Plener, P. et al. | 2006
- S189
-
S.17.04 Pharmacological treatment of adolescent depressionCohen, D. et al. | 2006
- S191
-
S.19.01 Psychoses converge via D2high receptorsSeeman, P. et al. | 2006
- S192
-
S.19.04 In vivo imaging of the D2high receptors occupancy by antipsychotics in SchizophreniaGraff, A. / Mamo, D. / Kapur, S. et al. | 2006
- S193
-
S.20.02 Neuroendocrine controls of sleepSteiger, A. / Kimura, M. / Kluge, M. / Schussler, P. et al. | 2006
- S194
-
S.20.05 Genetic aspects of sleepTafti, M. et al. | 2006
- S195
-
S.21.05 The beta-3-adrenergic receptor in anxiety disorders and their treatmentStemmelin, J. / Cohen, C. / Griebel, G. et al. | 2006
- S196
-
S.22.05 Very early onset schizophreniaRapoport, J. et al. | 2006
- S197
-
S.23.03 Neuroimaging in Alzheimers diseaseFox, N. C. et al. | 2006
- S198
-
S.24.03 Role of extrasynaptic GABA in hippocampusOrser, B. A. / Martin, L. J. / Cheng, V. Y. / Bonin, R. P. et al. | 2006
- S200
-
S.25.03 Smoking cessation treatment in patients with depression: outcomes, relapse vulnerability factors, and targeted inventionsHitsman, B. et al. | 2006
- S201
-
S.26.01 Neurotransmitter genes in causation and treatment responseGorwood, P. / Hamdani, N. / Dubertret, C. / Boni, C. et al. | 2006
- S202
-
S.27.02 Social isolation and brain functionMarsden, C. / Bianchi, M. / Pardon, M. C. / Porkess, V. / Fone, K. C. et al. | 2006
- S203
-
S.28.02 Influence of variants of TPH2 on the regulation of the central serotonin systemCaron, M. G. / Zhang, X. / Beaulieu, J. M. / Gainetdinov, R. R. / Sotnikova, T. et al. | 2006
- S205
-
E.04.01 Diagnosis and assessmentof adult ADHDBuitelaar, J. K. et al. | 2006
- S206
-
E.06.01 Gender differences: focus on addictionFischer, G. / Ebner, N. / Winklbaur, B. / Thau, K. et al. | 2006
- S209
-
P.1.a.002 Protective effect of haplotype of dysbindin gene (DTNBP1) on chromosome 6p22.3 to major depressive disorderKim, J. J. / Pae, C. U. / Kim, T. S. / Lee, C. U. / Lee, S. J. / Lee, C. / Jun, T. Y. / Paik, I. H. et al. | 2006
- S210
-
P.1.a.005 Association studies of the CT repeat polymorphism in the cholecystokinin B receptor gene with the diagnosis and the response of pharmacotherapy in Korean patients with panic disorderKim, W. et al. | 2006
- S211
-
P.1.a.007 Retinoid function related genes do not cause psychosis in a large inbred familyOzer, S. / Akyn, B. / Ulusahin, A. / Akarsu, N. et al. | 2006
- S213
-
P.1.a.010 The C270T and Val66Met polymorphisms of brain-derived neurotrophic factor in schizophreniaJuhasz, A. / Rimanoczy, A. / Keri, S. / Cimmer, C. / Szekeres, G. / Szendi, I. / Janka, Z. et al. | 2006
- S214
-
P.1.a.012 Transcripts expression profile of the genes assayed with the oligonucleotide microarray technique in young women with anorexia nervosaJanas-Kozik, K. M. / Stachowicz, S. M. / Krupka-Matuszczyk, K. M. / Mazurek, M. U. et al. | 2006
- S215
-
P.1.a.014 Expressed gene differences on .uoxetine treatment in rat hippocampusPaik, K. C. / Choi, J. H. / Han, C. H. et al. | 2006
- S216
-
P.1.a.015 Strain differences in susceptibility to unpredictable chronic mild stress as assessed by hippocampal gene expression profilingPaya-Cano, J. L. / Sluyter, F. / Mineur, Y. S. / Fernandes, C. / Crusio, W. E. / Schalkwyk, L. C. et al. | 2006
- S217
-
P.1.b.001 Registration of multiunit activity and analysis of neuro-neuronal, cardio-neuronal and respiratory-neuronal temporal relationshipsPrudnikau, H. et al. | 2006
- S218
-
P.1.b.003 Non-invasive measurement of vagus activity in the brainstem - a methodological progress towards earlier diagnosis of dementias?Fallgatter, A. J. / Polak, T. / Metzger, F. / Plichta, M. M. / Ringel, T. / Ehlis, A. C. et al. | 2006
- S219
-
P.1.b.005 Elevation of histamine H1 receptor mRNA level in hypothalamus of starved ratsFukui, H. et al. | 2006
- S220
-
P.1.b.007 Heart rate variability in patients with anxiety disordersDragasek, J. / Drimalova, M. / Durdik, P. / Migra, M. / Holla, G. et al. | 2006
- S221
-
P.1.b.009 Neural stem cell proliferation is significantly reduced in schizophrenia, but not in affective psychosesReif, A. / Fritzen, S. / Finger, M. / Strobel, A. / Schmitt, A. / Lesch, K. P. et al. | 2006
- S222
-
P.1.b.011 The differences of electroencephalogram coherence between schizophrenia and bipolar disorderPark, J. W. / Hong, K. S. / Park, S. D. / Lee, Y. S. et al. | 2006
- S224
-
P.1.c.002 Influence of nootropil on neuroplasticity of the brain cortex in conditions of hypokinesiaMelkonyan, K. et al. | 2006
- S225
-
P.1.c.004 Different Salvia species as ligands for selected central nervous system receptors: in vitro binding experimentsCavallo, F. / Nencini, C. / Capasso, A. / Bruni, G. / Micheli, L. et al. | 2006
- S226
-
P.1.c.006 Modification of formalin-induced nociception by different histamine receptor agonists and antagonistsFarzin, D. / Mansouri, N. et al. | 2006
- S227
-
P.1.c.008 The effects of venlafaxine on neurites growth of PC12 cellsLee, J. N. / Yang, B. H. et al. | 2006
- S228
-
P.1.c.010 From selective to highly selective SSRIs: the antinociceptive properties of four serotonergic antidepressantsSchreiber, S. / Pick, C. G. et al. | 2006
- S229
-
P.1.c.012 Anti-aversive effect of acute clomipramine and .uoxetine on fear-induced behaviour elicited by preys in confront with rattlesnakesElias-Filho, D. H. / Ubiali, W. A. / Coimbra, N. C. et al. | 2006
- S231
-
P.1.c.015 The role of voltage dependent sodium channels on the antidepressant-like effect of lamotrigineCodagnone, F. T. / Consoni, F. T. / Rodrigues, A. L. / Vital, M. A. / Andreatini, R. et al. | 2006
- S232
-
P.1.c.017 F15599, a highly selective serotonin 5-HT1A receptor agonist: in vitro affinity and efficacy profile at native rat and recombinant human 5-HT1A receptorsNewman-Tancredi, A. / Assie, M. B. / Cosi, C. / Bruins Slot, L. / Cussac, D. / Martel, J. C. et al. | 2006
- S234
-
P.1.c.020 Regulation of cytochrome P-450 activity by the brain dopaminergic systemWojcikowski, J. / Golembiowska, K. / Danie, W. A. et al. | 2006
- S235
-
P.1.c.022 Effects of prenatal exposure to nitric oxide synthase inhibitor on MK-801-elicited behavioural sensitivity in postnatal juvenile ratsPark, S. H. / Kim, G. J. / Chung, Y. I. et al. | 2006
- S236
-
P.1.c.024 Effects of haloperidol on intracellular calcium ion change in hamster insulinoma cellsKim, M. H. / Shin, J. H. / Park, K. C. / Park, G. S. / Gong, I. D. / Kim, T. H. et al. | 2006
- S237
-
P.1.c.026 a-1 Adrenergic receptors stimulation induces the proliferation of neural progenitor cellsHiramoto, T. / Watanabe, Y. et al. | 2006
- S238
-
P.1.c.027 Comparative efficacy of liposome-entrapped amiloride and free amiloride in animal models of seizures and serum potassium in miceAli, A. / Pillai, K. K. / Ahmad, F. J. / Vohora, D. et al. | 2006
- S239
-
P.1.c.030 Antidepressant treatment reduces fos-like immunoreactivity in different regions of periaqueductal gray matterOliveira, R. M. / Lino-de-Oliveira, C. / Carobrez, A. P. / De Lima, T. C. / Del Bel, E. A. / Guimaraes, F. S. et al. | 2006
- S240
-
P.1.c.032 Regulation of NA and GABA systems on DOI (agonist 5-HT2A/2C) anxiolytic-like effect in the four-plate test and cerebral localization of target receptorsMasse, F. / Hascoet, M. / Bourin, M. et al. | 2006
- S242
-
P.1.c.035 Gabapentin and topiramate protect rat neurons against staurosporine induced apoptosisAbramovici, S. / Bajenaru, O. / Popescu, B. O. et al. | 2006
- S243
-
P.1.c.037 Mitochondria as the memantine targetShevtsova, E. P. / Dubova, L. G. / Kireeva, E. G. / Bachurin, S. O. et al. | 2006
- S244
-
P.1.c.039 Effects of aripiprazole on dopamine and 5-HT function in rabbit brainKawamura, T. et al. | 2006
- S245
-
P.1.c.041 Fluorescence in vitro studies of human adenosine A2A and serotonin 5HT1A receptors homodimerizationLukasiewicz, S. / Blasiak, E. / Faron-Gorecka, A. / Wasylewski, Z. / Dziedzicka-Wasylewska, M. et al. | 2006
- S246
-
P.1.c.043 The effects of risperidone, olanzapine and haloperidol on enzyme activities in kidney tissue of ratsGulaboglu, M. / Halici, Z. / Aydin, N. / Cadirci, E. / Gul, M. / Suleyman, H. / Oral, E. et al. | 2006
- S247
-
P.1.c.045 The effects of risperidone, olanzapine and haloperidol on enzyme activities in erythrocytes and plasma of ratsHalici, Z. / Ozabacigil, F. / Aydin, N. / Gulaboglu, M. / Gul, M. / Suleyman, H. et al. | 2006
- S248
-
P.1.c.047 A double-blind, placebo-controlled investigation of the anxiolytic effects of XBD173 (AC-5216) and alprazolam using a CCK-4-induced panic challengeRupprecht, R. / Eser, D. / Schuele, C. / Kucher, K. / Merz, M. / Krebs-Brown, A. / Floesser, A. / Lataste, X. / Bruenig-Traebert, I. / Zaninelli, R. et al. | 2006
- S249
-
P.1.c.049 Descending serotonergic pathways play an inhibitory or facilitatory role in spinal pain processing by 5-HT7 or 5-HT3 receptors in acute and chronic painDogrul, A. / Ossipov, M. / Lai, J. / Porreca, F. et al. | 2006
- S250
-
P.1.d.002 Aggressive and hyperactive behavioural characteristics is increased in maternal social separated ratKwak, H. R. / Park, J. I. / Ko, H. J. / Kim, S. J. / Choi, Y. S. / Lee, H. J. et al. | 2006
- S251
-
P.1.d.004 Effects of a selective and brain penetrating 5-HT6 receptor antagonist in animal models of depression and anxietyWesolowska, A. / Nikiforuk, A. / Stachowicz, K. / Chojnacka-Wojcik, E. et al. | 2006
- S252
-
P.1.d.006 Behavioral phenotyping of sodium-myo-inositol cotransporter knockout mice with reduced brain inositolBersudsky, Y. / Shaldubina, A. / Johanson, R. / Buccafusca, R. / Agam, G. / Belmaker, R. H. / Berry, G. et al. | 2006
- S253
-
P.1.d.008 Alterations in the functional activity of the prodynorphin gene expression in selected brain regions are associated to increased preference for ethanol and the development of dependenceOliva, J. M. / Lorente, A. / Sanguino, E. / Manzanares, J. et al. | 2006
- S254
-
P.1.d.010 A dopaminergic mechanism recruited in the anti-punitive effect of the DOI in the four-plates test-retest paradigmRipoll, N. / Hascoet, M. / Bourin, M. et al. | 2006
- S255
-
P.1.d.011 Anxiolytic-like effects of NMDA-receptor antagonist injected into the ventral but not dorsal hippocampus in rats submitted to the elevated plus mazeHackl, L. P. / Carobrez, A. P. et al. | 2006
- S256
-
P.1.d.013 Memory performance of dopamine D3 knock-out mice (KO) mice pre-treated with beta-amyloid peptide is affected by cannabinoid CB1 receptor antagonistMicale, V. / Leggio, G. M. / Mazzola, C. / Tamburella, A. / Drago, F. et al. | 2006
- S257
-
P.1.d.015 Nociceptin and [Nphe1, Arg14, Lys 15]-nociceptin-NH2, UFP-101 restored opioid antinociception in morphine tolerant micePieretti, S. / Di Giannuario, A. et al. | 2006
- S258
-
P.1.d.017 Participation of the ventral hippocampus in the modulation of anxiety: role of nitric oxide, Rizzi A., et al., in the 2002, Br. behaviour of J. Pharmacol, 136, rats evaluated in the 303-311. elevated T-mazeCalixto, A. V. / Faria, M. S. / De Lima, T. C. et al. | 2006
- S259
-
P.1.e.001 Fusiform gyral volumes over two time points in adolescent-onset schizophreniaJames, A. / James, S. M. / Smith, D. M. / Day, C. et al. | 2006
- S261
-
P.1.e.006 Using a contextual binding task as a probe to explore hippocampal activation in schizophrenia: fMRI studiesBoulay, L. J. / Phillips, J. L. / Boyer, P. et al. | 2006
- S263
-
P.1.e.009 Low-resolution electromagnetic tomography (LORETA) source imaging compared with structural brain imaging in patients having organic brain lesionLee, S. H. / Kwon, G. H. / Park, Y. M. / Kim, H. / Lee, K. J. / Chung, Y. C. et al. | 2006
- S264
-
P.1.e.011 Effect of the acute tryptophan depletion on the neural response to happy and sad facesFusar Poli, P. / Allen, P. / Lee, F. / Surguladze, S. / Tunstall, N. / Fu, C. / Brammer, M. / Cleare, A. / McGuire, P. et al. | 2006
- S265
-
P.1.e.013 No differences in the ratio of dopamine transporter availability of putamen and caudate nucleus between patients with combined and with inattentive type of ADHDKrause, K. H. / La Fougere, C. / Krause, J. / Ackenheil, M. / Dresel, S. et al. | 2006
- S267
-
P.1.e.016 Intersubject differences in reappraisal strategies of negative emotion: a functional MRI studyViviani, R. / Ehrhard, K. / Lo, H. / Horn, A. B. et al. | 2006
- S268
-
P.1.e.018 Action monitoring and psychotic ego-disturbances: a functional MRI model to link selected psychopathologic symptoms to regional physiological dysfunctionsSchnell, K. / Heekeren, K. / Daumann, J. / Schnell, T. / Neukirch, A. / Moller-Hartmann2, W. / Heelmann, V. / Gouzoulis-Mayfrank, E. et al. | 2006
- S269
-
P.1.e.019 Reduction of prefrontal gray matter volume in first-episode schizophrenia independent of risperidone treatmentKasparek, T. / Prikryl, R. / Schwarz, D. / Kucerova, H. / Mikl, M. / Ceskova, E. / Krupa, P. et al. | 2006
- S270
-
P.1.e.021 Neural correlates of emotional self in bipolar disorder: a BOLD functional MRI 3 T studyRadaelli, D. / Benedetti, F. / Bernasconi, A. / Blasi, V. / Cadioli, M. / Colombo, C. / Dallaspezia, S. / Falini, A. / Scotti, G. / Smeraldi, E. et al. | 2006
- S271
-
P.1.e.023 Functional MRI investigation using visual and emotional memory induction paradigms in chronic depressionRavindran, A. V. / Smith, A. / Cameron, C. / Bhatla, R. / Cameron, I. et al. | 2006
- S273
-
P.1.e.026 A 3 T BOLD functional MRI study of the neural underpinnings of depressionBernasconi, A. / Benedetti, F. / Blasi, V. / Cadioli, M. / Colombo, C. / Dallaspezia, S. / Falini, A. / Radaelli, D. / Scotti, G. et al. | 2006
- S274
-
P.1.f.001 Cognitive testing in early-phase clinical trials: development of a rapid computerized test battery and application in a simulated Phase I studyCollie, A. / Darekar, A. / Maruff, P. / Snyder, P. / Huggins, J. P. et al. | 2006
- S275
-
P.1.f.004 Neurocognitive function in patient with Hwa-byung and major depressive disorderChoi, J. H. / Lee, S. H. / Yun, Y. H. / Han, C. H. et al. | 2006
- S276
-
P.1.f.006 High frequency repetitive TMS over the right dorsolateral prefrontal cortex: influence on Stroop task performanceVanderhasselt, M. A. / De Raedt, R. / Baeken, C. / Clerinx, P. / Leyman, L. / Dhaenen, H. et al. | 2006
- S280
-
P.1.g.001 Increased CSF cholecystokinin, NPY and GABA levels in pathological gamblingNordin, C. / Sjodin, I. et al. | 2006
- S281
-
P.1.g.003 Two cases of the induction of EEG seizure during long-term rapid-rate TMSZyss, T. / Zieba, A. / Dudek, D. / Sawicki, B. / Krawczyk, A. / Siwek, M. et al. | 2006
- S283
-
P.2.a.002 A geriatric depression scale detects depression in Hong Kong Chinese elderly patients with pneumoconiosis?Tang, W. K. / Lum, C. M. / Ungvari, G. S. / Chiu, H. F. et al. | 2006
- S284
-
P.2.a.003 Treatment resistant depression: response to prednisolone supression testJuruena, M. F. / Papadopoulos, A. S. / Poon, L. / Lightman, S. / Cleare, A. J. / Pariante, C. M. et al. | 2006
- S285
-
P.2.a.005 Severe depression without ICD-10 somatic syndrome does exist: clinical characteristics and diagnostic efficiency of somatic symptomsThuile, J. / Even, C. / Rouillon, F. / Guelfi, J. D. et al. | 2006
- S286
-
P.2.a.007 "Difficult depression" at private psychiatric clinics throughout France: an epidemiological survey (DEDICACE survey)Bougerol, T. / Gerard, A. / Bouhours, P. / Moreau-Mallet, V. et al. | 2006
- S287
-
P.2.a.009 Natural killer T cell patients with major depressive disorderJeon, Y. W. / Han, S. I. / Park, E. J. et al. | 2006
- S288
-
P.2.a.011 A systematic review and meta-analysis on the efficacy of brief psychotherapies and pharmacotherapy in the acute treatment of depressionBallesteros, J. / Goemes, I. / Gonzalez-Pinto, M. A. / Rueda, J. R. / Querejeta, I. / Retolaza, A. et al. | 2006
- S290
-
P.2.a.015 Addition of atomoxetine for depression incompletely responsive to sertraline: a randomized, double-blind, placebo-controlled studyMichelson, D. / Adler, L. A. / Amsterdam, J. D. / Dunner, D. L. / Nierenberg, A. A. / Reimherr, F. W. / Schatzberg, A. F. / Kelsey, D. K. / Feldman, P. D. / Levine, L. R. et al. | 2006
- S291
-
P.2.a.016 Depression in Chinese patients with Parkinsons and clinical determinantsTang, W. K. / Chan, D. M. / Chiu, H. F. / Ungvari, G. S. / Wong, K. S. / Mok, V. et al. | 2006
- S292
-
P.2.a.018 Bupropion efficacy in major depressive disorder and alcohol dependence dual diagnosisVasile, D. / Sarmache, M. / Vasile, M. L. / Gheorghe, M. D. et al. | 2006
- S293
-
P.2.a.020 High cholesterol, triglycerides, and body-mass index in suicide attempters: a population-based studyBrunner, J. / Bronisch, T. / Pfister, H. / Jacobi, F. / Hoefler, M. / Wittchen, H. U. et al. | 2006
- S294
-
P.2.a.021 Depression and socio-economic status: an 8-year longitudinal population-based studyLorant, V. / Croux, C. / Weich, S. / Deliege, D. / Mackenbach, J. / Ansseau, M. et al. | 2006
- S295
-
P.2.a.023 Maternal suicidality and risk of suicidality in offspring: findings from a community studyLieb, R. / Bronisch, T. / Hoefler, M. / Schreier, A. / Wittchen, H. U. et al. | 2006
- S296
-
P.2.a.025 Predictors of response to vagus nerve stimulationBrodesser, D. / Frick, C. / Hosten, S. / Axmacher, N. / Kosel, M. / Kuehn, K. U. / Brannan, S. / Maier, W. / Schlaepfer, T. E. et al. | 2006
- S297
-
P.2.a.028 Mania, hypomania, and suicidality: findings from a prospective community studyBronisch, T. / Schwender, L. / Hoefler, M. / Wittchen, H. U. / Lieb, R. et al. | 2006
- S298
-
P.2.a.030 Fatigue correlates in major depression: preliminary findingsFerentinos, P. P. / Kontaxakis, V. P. / Havaki-Kontaxaki, B. J. / Dikeos, D. G. / Soldatos, C. R. et al. | 2006
- S299
-
P.2.a.031 Serotonin transporter promoter genetic characterization: possible pharmacogenetic implications of rare allelesPirovano, A. / Lorenzi, C. / Aartioli, P. / Marino, E. / Catalano, M. / Smeraldi, E. et al. | 2006
- S300
-
P.2.a.034 RAPSODY registry of patients with painful symptoms and observation of depression and anxietyMignon, A. / Linkowski, P. / Van Heeringen, C. / Dramaix, M. / Leyman, S. et al. | 2006
- S302
-
P.2.b.002 Depressive-like phenotype in mice lacking cannabinoid CB1 receptorsValverde, O. / Aso, E. / Ozaita, A. / Valdizan, E. / Pazos, A. / Maldonado, R. et al. | 2006
- S303
-
P.2.b.004 Functional activity of a2-adrenoceptors in postmortem frontal cortex of depressed suicide victimsDiez-Alarcia, R. / Valdizan, E. M. / Gonzalez-Maeso, J. / Garcia-Sevilla, J. A. / Pazos, A. / Meana, J. J. et al. | 2006
- S304
-
P.2.b.006 Allosteric modulation of GABAB receptor coupling in rat brain: G-protein subtype dependence revealed by immunocapture scintillation proximity assaysMannoury La Cour, C. / Herbelles, C. / Millan, M. J. et al. | 2006
- S305
-
P.2.b.008 Antidepressant-like activity of Wf-516, an antagonist of 5-HT1A receptors and inhibitor of 5-HT reuptake, in a chronic mild stress model of depression in ratPapp, M. / Gruca, P. / Litwa, E. / Lason, M. / Przegalinski, E. et al. | 2006
- S306
-
P.2.b.010 Oxytocin, vasopression and anxiety in major depression: ago-antagonist neurohormonesScantamburlo, G. / Hansenne, M. / Fuchs, S. / Pitchot, W. / Reggers, J. / Marechal, P. / Pinto, E. / Ansseau, M. / Legros, J. J. et al. | 2006
- S307
-
P.2.b.011 Copper as trait marker of major depressive episodeFontana, M. / Squitti, R. / Cesaretti, S. / Bevacqua, M. G. / Ventriglia, M. / Ribolsi, M. / Zuppi, P. L. / Rossini, P. M. et al. | 2006
- S308
-
P.2.b.013 Neuropeptides in human cerebrospinal fluid and in brains of animal models of depression - effects of treatmentMathe, A. A. / Nikisch, G. / Agren, H. / Baumann, P. / El Khoury, A. / Gruber, S. H. / Husum, H. / Jimenez-Vasquez, P. / Wortwein, G. / Andersson, W. et al. | 2006
- S309
-
P.2.b.015 The infralimbic cortex modulates stress-induced coping behaviour - implications for depressionSlattery, D. A. / Cryan, J. F. et al. | 2006
- S310
-
P.2.b.017 Biologic epistasis between SERT and BDNF: complex genetic mechanisms of depressionPezawas, L. P. / Goldman, A. L. / Verchinski, B. A. / Mattay, V. A. / Callicott, J. H. / Kolachana, B. S. / Straub, R. E. / Egan, M. F. / Meyer-Lindenberg, A. / Weinberger, D. R. et al. | 2006
- S311
-
P.2.b.019 Behavioural characterization of mice knockout for the nociceptin/orphanin FQ receptor gene in animal models of anxietyGavioli, E. C. / Marzola, G. / Calo, G. et al. | 2006
- S313
-
P.2.c.002 Efficacy of milnacipran augmentation of nicotine replacement therapy on post-cessation mood and anxiety in smokers with previous history of major depressionBerlin, I. / Aubin, H. J. / Mansuy, L. / Lagrue, G. et al. | 2006
- S314
-
P.2.c.004 Changes in sexual functions under mirtazapine treatment - primary data of a national, multicentre, prospective observational study in depressed patientsOsvath, P. / Fekete, S. / Voros, V. / Almasi, J. et al. | 2006
- S315
-
P.2.c.006 Efficacy and safety of bupropion extended release in elderly patients with major depressive disorderChrzanowski, W. / Rousseau, R. / Hewett, K. / Gee, M. D. / Wightman, D. / Richard, N. E. / Modell, J. G. / Goodale, E. P. et al. | 2006
- S316
-
P.2.c.008 Is it appropriate to combine conceptually related scores in meta-analyses? - A Monte Carlo simulation approach for antidepressant trialsBallesteros, J. / Guemes, I. et al. | 2006
- S317
-
P.2.c.010 Impact of the melatonergic antidepressant agomelatine on sleep-wake rhythms of depressed patientsGuilleminault, C. / Quera-Salva, M. A. et al. | 2006
- S319
-
P.2.c.013 Antidepressant efficacy of agomelatine 25-50 mg versus venlafaxine 75 -150 mg: two randomized, double blind studiesKennedy, S. H. / Guilleminault, C. et al. | 2006
- S320
-
P.2.c.015 Effect of mirtazapine for insomnia in patients with major depressive episode: a polysomnographic studyKim, H. / Lee, K. J. / Lee, S. H. et al. | 2006
- S321
-
P.2.c.017 Antidepressant efficacy of agomelatine in major depressive disorder:meta-analysis of three pivotal studiesMontgomery, S. A. / Olie, J. P. / Kennedy, S. H. et al. | 2006
- S322
-
P.2.c.019 Two-year maintenance treatment study assessing recurrence prevention with venlafaxine XR in patients with recurrent unipolar major depressionKeller, M. / Yan, B. / Dunner, D. / Ferguson, J. / Friedman, E. / Gelenberg, A. / Hirschfeld, R. M. / Kocsis, J. / Kornstein, S. / Nemeroff, C. et al. | 2006
- S323
-
P.2.c.020 The efficacy of the oestrogen substitution associated with antidepressants in the treatment of menopausal depressionDan, I. A. / Grimberg, M. et al. | 2006
- S324
-
P.2.c.022 Mirtazapine versus tricyclic antidepressants for the treatment of depression, anxiety and distressing symptoms of cancerCankurtaran, E. S. / Soygur, A. H. / Ozalp, E. / Turhan, L. et al. | 2006
- S325
-
P.2.c.024 Is mirtazapine in combination with perospirone efficacious in drug resistant depression? - Via 5-HT1A receptor activationMorita, M. / Nakayama, K. / Nakajyo, R. / Kusaka, A. / Kodaka, H. / Miyata, H. et al. | 2006
- S327
-
P.2.c.027 Suicidal behaviour and psychopharmaco-therapy in urgent psychiatry outpatients departmentPregelj, P. et al. | 2006
- S328
-
P.2.c.029 Early sustained improvement with escitalopram leads to high response ratesBurke, W. J. / Korotzer, A. / Saikali, K. et al. | 2006
- S329
-
P.2.c.031 Venlafaxine/mirtazapine-combination in treatment-resistant major depressionUllrich, H. / Pach, J. L. / Kudling, R. / Klieser, E. et al. | 2006
- S330
-
P.2.c.033 Clinical effectiveness of lamotrigine in recurrent major depressive disorder, resistant to other therapiesFricchione Parise, V. et al. | 2006
- S331
-
P.2.c.035 Research update from the latest STARD findingsTrivedi, M. H. / Fava, M. / Nierenberg, A. A. / Warden, D. / Wisniewski, S. R. / Rush, A. J. et al. | 2006
- S332
-
P.2.c.037 Depression:characteristics of patients who receive adequate, inadequate, or no treatment at allZivanovic, O. et al. | 2006
- S333
-
P.2.d.002 Wf-516, a novel antidepressant with dual serotonergic activity: II. Pharmacological profiles ex vivo and in vivo to monoamine transporters in comparison with standard antidepressantMaeda, J. / Morio, Y. / Katayama, J. / Horie, S. / Inaba, K. / Nishiyama, A. / Eguchi, J. / Saito, K. et al. | 2006
- S334
-
P.2.d.004 Evaluation of antidepressant activities of rose oil and geranium oil in the forced swim test in mouseKhalaj, L. / Farzin, D. et al. | 2006
- S336
-
P.2.d.007 Proteomic analysis of hippocampus and frontal cortex in a rat model of depression with gene-environment interaction and antidepressant treatmentCarboni, L. / Piubelli, C. / Vighini, M. / El Khoury, A. / Gruber, S. / Anderssen, W. / Mathe, A. A. / Aitchison, K. J. / Mallei, A. / Giambelli, R. et al. | 2006
- S337
-
P.2.d.009 Agomelatine, a novel pharmacological approach to treating depressionHamon, M. / Millan, M. J. et al. | 2006
- S338
-
P.2.d.011 Effects of the novel antidepressant agomelatine (S 20098) and fluoxetine in chronically stressed tree shrews, an animal model of depressionFuchs, E. / Schmelting, B. / Mocaer, E. et al. | 2006
- S339
-
P.2.d.013 TC-2216: anti-depressant effects through selective modulation of neuronal nicotinic receptorsLippiello, P. M. / Bencherif, M. / Gatto, G. J. / Jordan, K. G. / Traina, V. M. et al. | 2006
- S340
-
P.2.d.015 Galanin enhances and a galanin antagonist attenuates depression-like behaviour in the ratKuteeva, E. / Wardi, T. / Hokfelt, T. / Ogren, S. O. et al. | 2006
- S342
-
P.2.d.018 Antidepressant-like effects of gabapentin and GABA-lactam analogues in the forced swimming test and in the tail suspension testMantovani, M. / Kaster, M. P. / Feuerstein, T. J. / Rodrigues, A. L. et al. | 2006
- S343
-
P.2.d.020 Antidepressant-like effect of guanosine in the forced swimming test and in the tail suspension testKaster, M. P. / Bonetti, K. M. / Santos, A. R. / Rodrigues, A. L. et al. | 2006
- S344
-
P.2.d.022 The modified Tail Suspension Test (mTST): a new paradigm to categorize antidepressants. Effects of classical and atypical opiatesBerrocoso, E. / Gibert-Rahola, J. / De Benito, M. D. / Mico, J. A. et al. | 2006
- S345
-
P.2.d.024 5-HT1A receptor antagonism reverses and prevents fluoxetine-induced sexual dysfunction in rats: clinical implicationsSukoff Rizzo, S. J. / Schechter, L. E. / Rosenzweig-Lipson, S. et al. | 2006
- S346
-
P.2.e.001 Bipolar diathesis of unipolar treatment resistant depressionBahk, W. M. / Woo, Y. S. / Chae, J. H. / Jun, T. Y. / Kim, K. S. / Kim, W. et al. | 2006
- S348
-
P.2.e.005 Elevated urine Adam12 protein levels in lithium-treated bipolar patientsBersudsky, Y. / Nadri, C. / Belmaker, R. H. / Agam, G. et al. | 2006
- S349
-
P.2.e.007 Dopamine function in bipolar depressed patientsMonreal Ortiz, J. A. / Duval, F. / Mokrani, M. C. / Pinault, G. / Fattah, S. / Chokmani, N. / He, J. / Champeval, C. / Macher, J. P. et al. | 2006
- S350
-
P.2.e.009 Body weight changes in patients with acute mania treated with combination of mood stabilizer and atypical antipsychotic or typical antipsychoticKang, M. H. / Jeon, J. S. / Kim, C. E. / Lee, J. S. / Bae, J. N. et al. | 2006
- S351
-
P.2.e.011 Aggressive behaviour during acute mania: a cross-sectional study with 173 different manic patientsMosquera, F. / Barbeito, S. / Garcia del Moral, E. / Alvarez de Eulate, S. / Lopez, P. / Casado, M. / Gonzalez-Pinto, A. et al. | 2006
- S352
-
P.2.e.013 Symptoms of bipolarity in patients with eating disordersRybakowski, F. / Kaminska, K. et al. | 2006
- S353
-
P.2.e.015 The efficacy and tolerability of quetiapine monotherapy in acute maniaYoon, B. / Bahk, W. M. / Lee, J. / Won, S. / Lee, S. / Min, K. / Jon, D. / Chung, S. et al. | 2006
- S354
-
P.2.e.017 Safety, tolerability and ef .cacy of rapidly-initiated quetiapine in acutely ill patients with bipolar I disorderCobo, I. / Hernandez, J. / Vazquez-Gutierrez, F. / Galan, J. L. / Tafalla, M. et al. | 2006
- S355
-
P.2.e.019 Specificity of effect of quetiapine for depressive symptoms in bipolar disorderHirschfeld, R. M. / Calabrese, J. R. et al. | 2006
- S356
-
P.2.f.001 Cognitive functions and neurological soft signs among patients with bipolar disorder, trait or state marker?Rabie, M. / Sadek, A. / Soliman, A. / Ramy, H. et al. | 2006
- S357
-
P.2.g.001 Diagnostic stability in major depressive disorder as according to DSM-IVBahk, W. M. / Woo, Y. S. / Chae, J. H. / Jun, T. Y. / Kim, K. S. et al. | 2006
- S359
-
P.2.g.004 Severity of depression during the first year of vagus nerve stimulation in the group of non-respondersFrick, C. / Hosten, S. / Brodesser, D. / Kosel, M. / Axmacher, N. / Kuehn, K. U. / Brannan, S. / Maier, W. / Schlaepfer, T. E. et al. | 2006
- S360
-
P.2.g.006 Disparity in the rate of depression and use of antidepressants in the USA by ethnicity/race: 1992-2003Sclar, D. A. / Skaer, T. L. / Robison, L. M. et al. | 2006
- S361
-
P.2.g.008 Serum zinc level as potential marker in recurrent depressive disorderSiwek, M. / Dudek, D. / Datka, W. / Zieba, A. / Pilc, A. / Nowak, G. et al. | 2006
- S363
-
P.2.h.002 Plasma levels of nitric oxide metabolites in patients with postpartum depressionLee, B. H. / Shin, Y. C. / Kim, Y. K. / Kim, K. H. et al. | 2006
- S364
-
P.3.a.002 Elevated plasma copper/zinc ratios in patients with schizophreniaFarzin, D. / Mansouri, N. / Yazdani, T. et al. | 2006
- S365
-
P.3.a.004 Long acting risperidone in treatment of non-compliant bipolar patientsCetin, M. / Basoglu, C. / Ebrinc, S. U. / Semiz, B. / Algul, A. / Oguz, M. et al. | 2006
- S366
-
P.3.a.005 Exploring the socio-cultural components of prescription patterns in schizophrenia: a comparative studyXiang, Y. T. / Weng, Y. Z. / Ungvari, G. S. / Leung, C. M. / Tang, W. K. et al. | 2006
- S367
-
P.3.a.007 Measuring catatonia:application of an item response theory modelUngvari, G. S. / Wong, E. / Leung, S. K. / Tan, W. K. et al. | 2006
- S368
-
P.3.a.008 Schizophrenia with catatonic features: a factor analytic studyGoggins, W. / Ungvari, G. S. / Leung, S. K. / Ng, F. S. et al. | 2006
- S369
-
P.3.a.010 Risperidone long-acting injection: a one year observational study in a naturalistic settingPatel, M. X. / Young, C. / David, A. S. / Taylor, D. M. et al. | 2006
- S370
-
P.3.a.012 Low concentration of plasma nitric oxide metabolites in schizophrenic patientsLee, B. H. / Kim, Y. K. / Lee, K. M. et al. | 2006
- S372
-
P.3.a.016 Pharmacotherapy in schizophrenic patients and quality of life of their family membersTrajanovic, L. / Skakic, O. / Zikic, O. et al. | 2006
- S373
-
P.3.a.018 Vitamin D deficiency and impaired parathormone metabolism as a risk factor of low bone mineral density in patients with diagnosis of schizophrenia treated with second generation antipsychoticsWyszogrodzka-Kucharska, A. / Rabe-Jablonska, J. et al. | 2006
- S374
-
P.3.a.020 Subgroups within schizophrenia differentiated by clinical and neurocognitive parametersSzendi, I. / Cimmer, C. / Csifcsak, G. / Szekeres, G. / Kovacs, A. Z. / Galsi, G. / Racsmany, M. / Boda, K. / Janka, Z. et al. | 2006
- S375
-
P.3.a.021 Examination of specific genetic aspects of the dopaminergic neurotransmission and neuronal plasticity in neurocognitive subgrouping of schizophreniaSzendi, I. / Juhasz, A. / Szekeres, G. / Cimmer, C. / Csifcsak, G. / Kovacs, A. Z. / Rimanoczy, A. / Galsi, G. / Boda, K. / Janka, Z. et al. | 2006
- S376
-
P.3.a.023 Infiuence of glycine on cognitive functions in schizophreniaStrzelecki, D. / Rabe-Jablonska, J. et al. | 2006
- S377
-
P.3.a.025 Open-label randomized trial comparing the efficacy and tolerability of quetiapine and olanzapine in first episode psychosis in adolescentsParellada, M. J. / Moreno, D. / Ruiz-Sancho, A. / Medina, O. / Arango, C. et al. | 2006
- S378
-
P.3.a.027 In fluences of polymorphisms of beta adrenergic receptors in the psychopharmacological treatment of schizophreniaSpellmann, I. / Riedel, M. / Musil, R. L. / Douhet, A. / Dehning, S. / Zill, P. / Muller, N. / Moller, H. J. / Bondy, B. et al. | 2006
- S380
-
P.3.a.030 Evidence that the outcome of developmental expression of psychosis is worse for adolescents growing up in an urban environmentWittchen, H. U. / Spauwen, J. / Krabbendam, L. / Lieb, R. / Van Os, J. et al. | 2006
- S381
-
P.3.a.032 Cognitive efficacy of quetiapine and olanzapine in early onset first episode psychosisRobles, O. / Zabala, A. / Parellada, M. J. / Ruiz, A. / Moreno, M. D. / Burdalo, M. T. / Arango, C. et al. | 2006
- S382
-
P.3.a.034 Negative symptoms of schizophrenia: analysis of a multinational, cross-sectional survey of physician perceptionsLecrubier, Y. / Perry, R. / Milligan, G. / Leeuwenkamp, O. et al. | 2006
- S384
-
P.3.a.037 Quality of life in bipolar type I disorder and schizophrenia in remission:clinical and neurocognitive correlatesBrissos, S. / Dias, V. V. / Carita, A. I. et al. | 2006
- S385
-
P.3.a.039 Onset of action of oral paliperidone extended-release tablets in patients with acute schizophrenia: pooled results from three 6-week controlled studiesKramer, M. / Nuamah, I. / Lim, P. / Eerdekens, M. et al. | 2006
- S387
-
P.3.a.042 Clinical course, social functioning, quality of life & medication tolerability in previously untreated patients with schizophrenia: 36-month results from the European schizophrenia outpatient health outcomes (SOHO) studyNovick, D. / Suarez, D. / Brown, J. / Gasquet, I. / Haro, J. M. et al. | 2006
- S388
-
P.3.a.044 Tobacco, alcohol and cannabis use in Tunisian patients with schizophreniaLaqueille, X. / Ghodhbane, S. / Nacef, F. / Choubani, Z. / Nehdi, M. / Douki, S. / Dervaux, A. et al. | 2006
- S389
-
P.3.a.046 Pseudophaeochromocytoma syndrome caused by clozapine therapy - a case reportSobanski, T. / Wagner, G. / Schubert, S. / Dafov, I. et al. | 2006
- S390
-
P.3.a.048 Insight in schizophrenia: clinical correlates and relationship to functioningGharabawi, G. M. / Bossie, C. A. / Bouhours, P. / Turkoz, I. / Kujawa, M. et al. | 2006
- S391
-
P.3.b.001 Polymorphisms of dysbindin gene (DTNBP1) and schizophrenia in the Korean populationJun, T. Y. / Bahk, W. M. / Chae, J. H. / Pae, C. U. / Jung, Y. E. / Lee, B. W. / Bang, S. K. / Woo, Y. S. et al. | 2006
- S392
-
P.3.b.002 Stereotypy in schizophrenic patients on atypical antipsychotics versus conventional neurolepticsMorrens, M. / Hulstijn, W. / Sabbe, B. G. et al. | 2006
- S393
-
P.3.b.004 Evidence of a cortical disinhibition in schizophrenia: a transcranial magnetic stimulation studyBen Amor, C. / Galinowski, A. / Gueguen, B. / Bourdel, M. C. / Olie, J. P. / Douki, S. / Krebs, M. O. et al. | 2006
- S394
-
P.3.b.006 Relationship between glutathione peroxidase activity, glutathione and selenium levels in schizophrenic patientsMechri, A. / Mekhinini, A. / Ben Othman, L. / Fendri, C. / Gaha, L. / Kerkeni, A. et al. | 2006
- S395
-
P.3.b.008 Oxidative stress and neurodevelopmental abnormalities in schizophreniaMechri, A. / Fendri, C. / Slama, H. / Ben Othman, L. / Kerkeni, A. / Gaha, L. et al. | 2006
- S396
-
P.3.c.001 A randomized double blind clinical trial in famotidine adjuvant therapy in schizophreniaFarzin, D. / Hosseini, S. H. / Shafaat, A. et al. | 2006
- S397
-
P.3.c.003 Olanzapine versus ziprasidone in parenteral administration in psychotic relapse of schizophreniaTudor, C. / Ungureanu, D. / Gheorghe, M. D. et al. | 2006
- S399
-
P.3.c.006 A pilot crossover study on QTc interval associated with olanzapine and risperidoneSu, K. P. / Huang, C. L. / Hsu, H. B. / Pariante, C. M. et al. | 2006
- S400
-
P.3.c.008 Weight change after switching from olanzapine tablets to olanzapine orally disintegrated tablets in obese patients with schizophreniaChawla, B. / Luxton-Andrew, H. et al. | 2006
- S401
-
P.3.c.010 Asenapine safety and tolerability in acute schizophrenia: a placebo-and risperidone-controlled trialPotkin, S. G. / Cohen, M. / Panagides, J. / Jina, A. et al. | 2006
- S402
-
P.3.c.012 Discontinuation rate of antipsychotic drugs in the treatment of first treated schizophreniaShim, J. C. / Choe, B. M. / Jae, Y. M. / Kim, J. G. / Kim, H. C. / Kim, S. G. et al. | 2006
- S404
-
P.3.c.015 Pre-attentive processes and attention: effect of risperidone for 6 weeks in untreated patients with schizophrenia and correlation with disorganizationAmado, I. / Daban, C. / Poirier, M. F. / Bourdel, M. C. / Willard, D. / Bouhours, P. / Loo, H. / Krebs, M. O. et al. | 2006
- S405
-
P.3.c.017 Adjunctive treatment with a dopamine partial agonist, aripiprazole for antipsychotic induced hyperprolactinemiaShim, J. C. / Kelly, D. L. / Jung, D. U. / Seo, Y. S. / Kim, Y. H. / Conley, R. R. et al. | 2006
- S406
-
P.3.c.019 Patient compliance and efficacy of quetiapine treatment in schizophrenia: results of six-month follow-up studyAlptekin, K. et al. | 2006
- S407
-
P.3.c.021 Patterns of antipsychotic-induced weight change: 3-year results from the intercontinental schizophrenia outpatient-health outcomes (IC-SOHO) studyDossenbach, M. / Pachecho, Z. / Toledo, D. / Cornejo, R. / West, T. / Lowry, A. et al. | 2006
- S408
-
P.3.c.022 Amelioration of symptomatology, Parkinsonism and neurocognitive dysfunction following dehydroepiandrosterone (DHEA) administration in schizophreniaStrous, R. D. / Stryjer, R. / Maayan, R. / Gal, G. / Eisner, D. / Weizman, A. et al. | 2006
- S409
-
P.3.c.024 Negative and cognitive symptomatology improvement during aripiprazole treatment in chronic schizophreniaGheorghe, M. D. / Voicu, V. A. / Vasile, D. / Vasiliu, O. / Grigorescu, G. et al. | 2006
- S410
-
P.3.c.026 Remission of tardive dyskinesia following the switch from clozapine to zotepine: 2-year follow-upLin, C. C. / Chen, J. Y. / Bai, Y. M. / Chen, T. T. / Wang, Y. C. / Liou, Y. J. / Lin, W. K. et al. | 2006
- S411
-
P.3.c.028 Effectiveness of aripiprazole versus standard of care treatment in patients with schizophrenia: the Schizophrenia Trial of Aripiprazole (STAR) studyKerwin, R. / LItalien, G. / Hanssens, L. / Marcus, R. N. / McQuade, R. / Carson, W. H. / Beuzen, J. N. et al. | 2006
- S412
-
P.3.c.030 Serotonin 2c receptor gene polymorphisms in association with extrapyramidal side-effects in schizophrenic patientsGunes, A. / Dahl, M. L. / Spina, E. / Scordo, M. G. et al. | 2006
- S413
-
P.3.c.032 Risperidone long acting im formulation in high risk of noncompliance bipolar patientsVasile, D. / Vasiliu, O. / Ojog, D. / Gheorghe, M. D. et al. | 2006
- S414
-
P.3.c.034 Comparing the use and outcomes of antipsychotics in the real worldTaylor, A. M. / Shajahan, P. / Carleton, R. et al. | 2006
- S415
-
P.3.c.036 Clinical efficacy, body weight change and cardiac safety of zotepine in schizophrenic patientsLin, W. W. / Chen, H. K. et al. | 2006
- S416
-
P.3.c.038 Switching from other second generation antipsychotics to zotepine in schizophrenic patients: an 12-week open-label studyChen, J. Y. / Chen, T. T. / Lin, C. C. / Bai, Y. M. / Wu, B. J. / Hung, C. H. et al. | 2006
- S417
-
P.3.c.040 The comparison of efficacy between aripiprazole and haloperidol in treatment of chronic schizophrenia and schizoaffective disorder: results for 16-week clinical studyKim, J. G. / Cho, D. H. / Lee, S. J. / Lee, J. K. / Wang, K. S. / Seo, Y. I. / Choi, S. J. / Joo, M. J. / Kim, H. D. / Lee, K. H. et al. | 2006
- S418
-
P.3.c.041 -759 C/T polymorphism of the 5-HT2C receptor gene and antipsychotic drug-induced weight gainRyu, S. H. / Jang, W. S. / Cho, E. Y. / Kim, S. K. / Lee, D. S. / Park, T. S. / Oh, S. H. / Hong, K. S. et al. | 2006
- S419
-
P.3.c.043 Association of leptin gene polymorphism with antipsychotic drug-induced weight gainRyu, S. H. / Jang, W. S. / Cho, E. Y. / Kim, S. K. / Lee, D. S. / Hong, K. S. et al. | 2006
- S420
-
P.3.c.045 Treatment of agitation caused by severe mental illness: data from the South London and Maudsley intensive care units trial evaluation (SLAMICUTE) studyMantua, V. / Travis, M. J. / Atakan, Z. / Isaac, M. B. / Isaac, M. T. / Smith, S. / Gilbert, D. / Komeh, J. / Shaw, A. / Sweeney, C. et al. | 2006
- S422
-
P.3.c.048 Antipsychotic safety: should we believe in guinea-pigsBarrocas, D. / Abreu, M. / Figueira, L. et al. | 2006
- S423
-
P.3.c.050 Psychopathology and metabolic syndrome (MS) in psychotic patients: the CLAMORS studyArango, C. / Bobes, J. / Aranda, P. / Carmena, R. / Garcia-Garcia, M. / Rejas, J. et al. | 2006
- S424
-
P.3.c.052 Quetiapine monotherapy is efficacious for depressive episodes of bipolar I and II disorder: a confirmatory double-blind study (BOLDER II)Thase, M. E. / Macfadden, W. / McCoy, R. / Chang, W. / Calabrese, J. R. et al. | 2006
- S425
-
P.3.c.054 Olanzapine, quetiapine, and risperidone in the treatment of first-episode psychosis: effectiveness and factors influencing adherence to treatmentMcEvoy, J. P. / Perkins, D. O. / Gu, H. / Hamer, R. M. / Lieberman, J. A. et al. | 2006
- S427
-
P.3.c.058 Emotion recognition deficit in first-episode schizophrenic patients and atypical antipsychoticsAmminger, G. P. / Werneck-Rohrer, S. W. / Aschauer, H. N. / Edwards, J. E. / Schloegelhofer, M. S. et al. | 2006
- S428
-
P.3.c.059 Clozapine and amisulpride in a treatment resistant schizophrenic patient with alcohol dependence and diabetes comorbidityDervaux, A. / Cazali, J. et al. | 2006
- S429
-
P.3.d.001 Effects of bifeprunox on the rat ventral tegmental area dopamine and dorsal raphe serotonin neuronal activityDahan, L. / Mnie-Filali, O. / Arnt, J. / Hertel, P. / Haddjeri, N. et al. | 2006
- S430
-
P.3.d.003 A cross-sectional study of adiponectin in patients with schizophreniaHanssens, L. / DeHert, M. / Van Eyck, D. / Wampers, M. / Scheen, A. / Peuskens, J. et al. | 2006
- S431
-
P.3.d.005 Effects of novel antipsychotics with preferential activity at D2-like and 5-HT1A receptors, in comparison with typical and atypical reference antipsychotics, in rodent models of cognition and memory deficitBardin, L. / Newman-Tancredi, A. / Depoortere, R. et al. | 2006
- S432
-
P.3.d.007 F15063, a novel antipsychotic with dopamine D2/D3 antagonist, 5-HT1A agonist and D4 partial agonist properties: III. Duration of brain D2-like receptor occupancy, antipsychotic-like activity and plasma concentration in rodentsAssie, M. B. / Bardin, L. / Auclair, A. L. / Consul-Denjean, N. / Sautel, F. / Kleven, M. S. / Depoortere, R. / Newman-Tancredi, A. et al. | 2006
- S434
-
P.3.d.010 Neonatal endotoxin administration induces behavioural changes in young adult rat males: implications for the etiopathogenesis of schizophreniaTejkalova, H. / Klaschka, J. / Stastny, F. et al. | 2006
- S435
-
P.3.d.012 The response of clozapine on midbrain dopamine neurons depends on endogenous concentration of kynurenic acidSchwieler, L. / Linderholm, K. R. / Nilsson, L. K. / Engberg, G. / Erhardt, S. et al. | 2006
- S436
-
P.3.d.014 Anti-S100 antibodies ameliorate haloperidol-induced catalepsy and do not change the activity of haloperidol in apomorphine-induced stereotypyDugina, J. L. / Kheifez, I. A. / Martyushev-Poklad, A. V. / Voronina, T. A. / Molodavkin, G. M. / Epstein, O. I. / Sergeva, S. A. et al. | 2006
- S439
-
P.3.d.019 Chronic olanzapine treatment affects intracellular signalling in selected subcellular compartments of rat prefrontal cortexFumagalli, F. / Frasca, A. / Sparta, M. / Drago, F. / Racagni, G. / Riva, M. A. et al. | 2006
- S440
-
P.3.d.021 Physostigmine reverses MK-801-induced but not amphetamine-induced effects on latent inhibition: focus on cholinergic treatments in schizophreniaBarak, S. / Weiner, I. et al. | 2006
- S441
-
P.3.d.023 Efficacy of a psychoeducational program for weight loss in patients who have experienced weight gain during treatment with olanzapineCastrogiovanni, S. / Simoncini, M. / Iovieno, N. / Cecconi, D. / Dell Agnello, G. / Donda, P. / Quadrigli, M. / Rossi, A. / Mauri, M. et al. | 2006
- S442
-
P.3.e.002 Clinical evaluation of levopromazine (methotrimeprazine) as add-on therapy in fibromyalgia managementMorillas-Arques, P. / Rodriguez-Lopez, C. M. / Vilchez, J. S. / Hidalgo, J. / Rico-Villademoros, F. / Calandre, E. P. et al. | 2006
- S443
-
P.3.e.003 Dissociation of working memory from decision-making in schizophreniaKweon, Y. S. / Lee, K. U. / Lee, S. J. / Kim, Y. T. / Kim, S. H. / Jeung, S. H. / Lee, H. K. / Lee, J. T. et al. | 2006
- S444
-
P.3.e.005 Influencing negative symptoms of schizophrenia with repetitive transcranial magnetic stimulation: a pilot studyPrikryl, R. / Ustohal, L. / Kasparek, T. / Kucerova, H. / Ceskova, E. / Skotakova, S. et al. | 2006
- S445
-
P.3.e.007 Risperidone oral solution, therapeutic possibility in treatment of acute and agitated psychotic patientsLasic, D. / Rubesa, G. / Dodig, G. / Katavic, Z. / Glavina, T. / Zuljan-Cvitanovic, M. et al. | 2006
- S446
-
P.3.e.009 Cognitive enhancement in schizophrenia: the role of dopamine and noradrenaline in the prefrontal cortexLopez-Garcia, P. / Snitz, B. / Smedley, K. / Carter, C. S. et al. | 2006
- S447
-
P.3.f.002 The 5-HT6 receptor antagonists, SB271,046 and SB258,585, enhance social memory and cholinergic transmission in rats: a comparison with 5-HT1A receptor partial agonistsLoiseau, F. / Millan, M. J. / Rivet, J. M. / Gobert, A. / De Groote, L. / Sicard, D. / Di Cara, B. / Cistarelli, L. / Billiras, R. / Dekeyne, A. et al. | 2006
- S448
-
P.4.a.001 A study of venlafaxine plus long-acting form of risperidone in patients with treatment-resistant obsessive compulsive disorder: preliminary resultsOzdemir, S. / Kocabasoglu, N. et al. | 2006
- S451
-
P.4.a.007 Natural course of obsessive compulsive disorder (OCD) over four years: findings from a prospective community study of adolescents and young adultsLieb, R. / Schwender, L. / Nocon, A. / Pfister, H. / Wittchen, H. U. et al. | 2006
- S452
-
P.4.a.009 Developmental trajectories of anxiety disorders in offspring at high risk for panic disorderBiederman, J. / Petty, C. / Hirshfeld-Becker, D. / Henin, A. / Henry, B. / Faraone, S. V. / Rosenbaum, J. F. et al. | 2006
- S453
-
P.4.a.011 Longitudinal course of posttraumatic stress disorder and posttraumatic stress disorder symptoms in a community sample of adolescents and young adultsPerkonigg, A. / Pfister, H. / Stein, M. B. / Hoefler, M. / Lieb, R. / Maercker, A. / Wittchen, H. U. et al. | 2006
- S455
-
P.4.a.014 Association and temporal relation of generalized anxiety and pain in the first three decades of life: a 10-year follow-up study among adolescents and young adultBeesdo, K. / Wittchen, H. U. / Guenther, A. / Lieb, R. et al. | 2006
- S456
-
P.4.a.016 Alcohol consumption in first stages of panic disorder: relationships with symptoms and impairmentRodriguez-Cabo, B. / Herran, A. / Ramirez, M. L. / Carrera, M. / Ayestaran, A. / Sierra-Biddle, D. / Hoyuela, F. / Vazquez-Barquero, J. L. et al. | 2006
- S457
-
P.4.a.018 The effects of D-cycloserine on a cognitive function task under different states of anxiety in healthy volunteersBailey, J. E. / Papadopoulos, A. / Nutt, D. J. et al. | 2006
- S458
-
P.4.a.020 Efficacy and safety of pregabalin for the treatment of generalized anxiety disorder in elderly patientsMontgomery, S. A. / Chatamra, K. / Baldinetti, F. / Whalen, E. et al. | 2006
- S459
-
P.4.a.022 Association study of limbic system-associated membrane protein gene polymorphisms in panic disorderMaron, E. / Koido, K. / Must, A. / Reimets, A. / Koks, S. / Vasar, E. / Vasar, V. / Shlik, J. et al. | 2006
- S460
-
P.4.b.002 The central neuropeptide S system: expression, pharmacology and behavioural significance of neuropeptide S receptorsLeonard, S. K. / Kouranova, E. / Bender, C. / Malberg, J. E. / Schechter, L. E. / Luo, B. / Platt, B. / Potestio, L. / Beyer, C. E. / Rosenzweig-Lipson, S. et al. | 2006
- S461
-
P.4.b.004 Stimulation of the lateral habenula inhibits a panic-like behaviour by activation of serotonin-1A receptors in the rat dorsal periaqueductal grayPobbe, R. L. / Bertoglio, L. J. / Zangrossi, H. et al. | 2006
- S462
-
P.4.b.006 Inhibition of nitric oxide synthase in the dorsolateral periaqueductal grey decreases behavioural consequences of predator exposure in ratsAguiar, D. C. / Guimaraes, F. S. et al. | 2006
- S464
-
P.4.c.001 Adjunctive quetiapine for SRI-resistant obsessive compulsive disorder: a meta-analysis of three randomised controlled treatment trialsFineberg, N. A. / Stein, D. J. / Carey, P. / Vythilingum, B. / Sivakumaran, T. / Seedat, S. / Westenberg, H. / Denys, D. / Premkumar, P. et al. | 2006
- S465
-
P.4.c.003 Predictors of clinical outcome in panic disorder: a pooled analysis of venlafaxine extended release short-term treatment studiesPollack, M. / Stein, D. J. / Mangano, R. / Entsuah, R. / Simon, N. et al. | 2006
- S466
-
P.4.c.005 Pregabalins efficacy in achieving remission in outpatients with generalized anxiety disorderWittchen, H. U. / Baldinetti, F. et al. | 2006
- S467
-
P.4.d.001 Effect of ELB139, a subtype selectivie benzodiazepine agonist, on EEG in ratsLangen, B. / Unverferth, K. / Rundfeldt, C. et al. | 2006
- S468
-
P.4.d.003 Brief exposure of mice to a predator induces memory impairment in the object recognition task-effects of acute and chronic treatment by diazepam and imipramineBertaina-Anglade, V. / Enjuanes, E. / Drieu la Rochelle, C. et al. | 2006
- S469
-
P.4.d.005 Pregabalin acts at calcium channel alpha2-delta type 1 proteins to prevent acute stress-induced increases in cerebellar cGMPCampbell, B. M. / Morrison, J. L. / Taylor, C. et al. | 2006
- S470
-
P.4.e.001 Low frequency repetitive transcranial magnetic stimulation for the treatment of patients with posttraumatic stress disorder: a double-blind, sham-controlled studySong, J. M. / Pae, C. U. / Lee, Y. J. / Bahk, W. M. / Jun, T. Y. / Hahm, W. / Chae, J. H. et al. | 2006
- S471
-
P.4.e.002 Deep brain stimulation of the ventral caudate nucleus in the treatment of obsessive-compulsive disorder and major depressionAouizerate, B. / Martin-Guehl, C. / Cuny, E. / Guehl, D. / Amieva, H. / Benazzouz, A. / Fabrigoule, C. / Allard, M. / Rougier, A. / Bioulac, B. et al. | 2006
- S472
-
P.4.e.004 Trait stability and agoraphobia in a one year follow up panic disorder sampleHoyuela, F. / Carrera, M. / Ramirez, M. M. / Rodriguez-Cabo, B. / Ayestaran, A. / Sierra-Biddle, D. / Herran, A. / Vazquez-Barquero, J. L. et al. | 2006
- S473
-
P.4.e.005 The effect of acute tryptophan depletion on challenge induced anxiety in anxiety disorder patients is independent of a history of depressionHood, S. D. / Argyropoulos, S. V. / Davies, S. J. / Hince, D. A. / Bell, C. J. / Nutt, D. J. / Potokar, J. et al. | 2006
- S474
-
P.4.f.001 Differential behaviour in the marble-burying test does not predict behavioural differences in generalized anxiety disorder modelsCosta, M. / Costa, C. R. / Gargano, A. C. / Ledvinka-Filho, E. et al. | 2006
- S475
-
P.4.f.003 EPIA -anxiety as a trait in SlovakiaHeretik, A. / Novotny, V. / Pecenak, J. / Ritomsky, A. et al. | 2006
- S476
-
P.5.a.002 Relationships between writing errors and cognitive impairment in elderly psychiatric patientsTamasan, S. C. / Reisz, D. et al. | 2006
- S477
-
P.5.a.004 Validity of the Korean version of the Mini-CogChoi, Y. M. / Lee, D. W. / Lee, J. Y. et al. | 2006
- S478
-
P.5.a.006 Impact of Apo-E genotype on the response to donepezil therapy in patients with Alzheimers diseaseScordo, M. G. / Varsaldi, F. / Arena, M. G. / Villa, M. L. / Lombardi, G. / Cordici, F. / Dahl, M. L. et al. | 2006
- S480
-
P.5.a.009 Effects of long term treatment with cholinesterase inhibitors on sleep EEG in patients with dementia of Alzheimer and frontotemporal typeHemmeter, U. M. / Rocamora, R. / Thum, A. / Giesler, M. / Haag, A. / Becker, A. / Krieg, J. C. et al. | 2006
- S481
-
P.5.a.011 Efficacy and safety of donepezil in vascular dementia:results from the largest double-blind trial in vascular dementia patientsRoman, G. / Black, S. / Royall, D. R. / Surick, I. / Kumar, D. / Schindler, R. / Posner, H. et al. | 2006
- S482
-
P.5.b.002 Magnetic resonance spectroscopy in patients with alcoholic dementiaGo, H. J. / Cheon, Y. H. / Ahn, K. / Kim, Y. D. / Kim, D. et al. | 2006
- S483
-
P.5.b.004 Effects of memantine on the activity of secretase enzymes in the human neuroblastoma cellsLahiri, D. K. / Chen, D. / Alley, G. M. / Banerjee, P. K. et al. | 2006
- S484
-
P.5.b.006 Age-dependent changes in hippocampal glutamate levels parallel learning impairment in APP/PS1 transgenic miceMinkeviciene, R. / Ihalainen, J. / Malm, T. / Keksa-Goldsteine, V. / Leguit, N. / Glennon, J. / Banerjee, P. K. / Tanila, H. et al. | 2006
- S486
-
P.5.d.002 Phospholipase D activation as a possible apoptotic signal in ischemic astrocytesKrzystanek, M. / Krupka-Matuszczyk, I. / Trzeciak, H. I. / Krzystanek, E. et al. | 2006
- S487
-
P.5.e.002 An open-label study of quetiapine for deliriumManeeton, N. / Maneeton, B. / Srisurapanont, M. et al. | 2006
- S488
-
P.5.e.004 A comparative study of haloperidol and quetiapine in the treatment of delirium: a preliminary randomized open label, flexible dose trialLee, Y. / Lee, J. / Rim, H. D. / Kim, S. H. / Chung, U. S. / Cho, G. A. / Won, S. H. et al. | 2006
- S489
-
P.6.a.001 Efficacy and safety of aripiprazole for the treatment of craving and relapse prevention in dually diagnosed alcohol dependent subjects: a pilot studyMartinotti, G. / Di Nicola, M. / Andreoli, S. / Di Maria, G. / Reina, D. / Janiri, L. et al. | 2006
- S492
-
P.6.a.007 Risks and pattern of alcohol withdrawal deliriumManeeton, B. / Burapakajornpong, N. / Srisurapanont, M. et al. | 2006
- S494
-
P.6.a.011 Childhood adversity associated with reduced central dopamine sensitivity later in life, a pre-morbid vulnerability to develop alcohol dependence?Schellekens, A. F. / Ellenbroek, A. / De Jong, C. A. / Buitelaar, J. K. / Verkes, R. J. et al. | 2006
- S495
-
P.6.a.013 Sleep problems in alcohol dependencePaparrigopoulos, T. J. / Tzavellas, E. O. / Liappas, J. A. / Soldatos, C. R. et al. | 2006
- S496
-
P.6.b.001 The endocannabinoid system in the effects of alcohol on limbic neurons:an in vivo electrophysiological studyPistis, M. / Perra, S. / Pillolla, G. / Muntoni, A. L. / Melis, M. et al. | 2006
- S498
-
P.6.b.004 Effect of amino acid derivatives and lipoic acid on lipid peroxidation and antioxidant systems indices in the rat brain during alcohol withdrawalPronko, P. S. / Khomich, T. I. / Bardina, L. R. / Satanovskaya, V. I. / Borodich, O. A. et al. | 2006
- S499
-
P.6.b.006 The role of epigenetic HERP dysregulation in patients with alcohol dependenceBleich, S. / Lenz, B. / Bonsch, D. / Frieling, H. et al. | 2006
- S500
-
P.6.c.001 Benzodiazepines misuse in outpatients treated by internistsSrisurapanont, M. / Suttajit, S. / Lerttrakarnnon, P. et al. | 2006
- S502
-
P.6.c.004 Are benzodiazepine expenses judiciously invested?Irurita, J. / Irurita, M. / Deniz, C. / Martinez Saavedra, M. T. / Culebras, C. / Rodriguez, M. S. / Ania, B. / Saavedra, J. M. / Chirino, R. / Sanchez, F. et al. | 2006
- S503
-
P.6.c.006 The treatment of heroin withdrawal with dextromethorphan in Han Chinese: a randomized double-blind placebo-controlled trialLin, W. W. / Tao, P. L. / Lee, J. F. / Lu, R. B. / Ko, H. C. et al. | 2006
- S504
-
P.6.c.008 One year retention rates and outcomes methadone and buprenorphine maintenance treatments: a nationwide prospective-longitudinal study of 2694 patientsWittchen, H. U. / Apelt, S. M. / Soyka, M. / Gastpar, M. / Backmund, M. / Goelz, J. / Kraus, M. / Tretter, F. / Schaefer, M. / Siegert, J. et al. | 2006
- S505
-
P.6.c.010 The effects of cannabinoids in man: a systematic review of neuroimaging studiesFagundo, A. B. / Martin-Santos, R. / Crippa, J. A. / Seal, M. / Atakan, Z. / McGuire, P. et al. | 2006
- S507
-
P.6.d.001 Ascorbic acid attenuates naloxone-induced withdrawal signs in morphine-dependent guinea-pigsFarzin, D. et al. | 2006
- S508
-
P.6.d.003 A morphometric evaluation of rat foetal cerebrum after maternal administration of morphine sulfateSadraie, S. H. / Kaka, G. et al. | 2006
- S509
-
P.6.d.005 mGlu1 receptor blockade attenuates cue- and nicotine-induced reinstatement of extinguished nicotine self-administration behaviour in ratsDravolina, O. / Zakharova, E. S. / Shekunova, E. V. / Zvartau, E. E. / Danysz, W. / Bespalov, A. Y. et al. | 2006
- S510
-
P.6.d.007 Evaluation of the role of 5-HT1A receptors in dorsal and median raphe nuclei on the morphine withdrawal syndrome in ratCharkhpour, M. / Nayebi, A. M. et al. | 2006
- S512
-
P.6.d.011 Gender differences in effects of MDMA, cannabinoid agonist and their combinations in miceKucerova, J. / Landa, L. / Slais, K. / Sulcova, A. E. et al. | 2006
- S513
-
P.6.d.013 GABA(B) receptor agonists and a positive modulator reduce the "depressive-like" behaviours in rats during cocaine abstinenceFilip, M. / Frankowska, M. / Golda, A. / Zaniewska, M. / Przegalinski, E. et al. | 2006
- S514
-
P.6.d.015 MDMA self-administration is abolished in serotonin transporter knockout miceTrigo Diaz, J. M. / Renoir, T. / Lanfumey, L. / Hamon, M. / Robledo, P. / Maldonado, R. et al. | 2006
- S516
-
P.6.d.018 New group of positive modulators of AMPA-receptors with cognition enhancing propertiesGrigoriev, V. V. / Lavrov, M. / Palyulin, V. A. / Zefirov, N. S. / Besnosko, B. K. / Bachurin, S. O. et al. | 2006
- S517
-
P.6.d.020 CB1 cannabinoid and m opioid receptors density and functionality are altered in rats self-administering either heroin or the CB1 receptor agonist WIN 55,212 -2Fattore, L. / Vigano, D. / Fadda, P. / Rubino, T. / Parolaro, D. / Fratta, W. et al. | 2006
- S518
-
P.6.d.022 Behavioural responses induced by nicotine in delta-opioid receptor knockout miceBerrendero, F. / Galeote, L. / Bura, A. / Kieffer, B. L. / Maldonado, R. et al. | 2006
- S519
-
P.6.d.024 C385A FAAH SNP is related to substance use disorder but not to schizophrenia in a Spanish sampleMartinez-Gras, I. / Ponce, G. / Rodriguez-Jimenez, R. / Rubio, G. et al. | 2006
- S520
-
P.6.e.002 Efficacy of sertraline in the treatment of alcohol dependenceLazarova, V. L. / Jakovcevska Kujundziska, M. J. / Filovska, V. F. / Krstevska, R. K. et al. | 2006
- S521
-
P.6.f.001 Is drive satisfaction mechanism ("antidrive") involved in substance addiction?Kostowski, W. / Beck, J. et al. | 2006
- S522
-
P.6.f.003 Effects of neonatal serotonin depletion on reinforcing and rewarding properties of cocaine in ratsStefanski, R. / Krzascik, P. / Kolomanska, P. / Rock, P. / Wyszogrodzka, E. / Kostowski, W. et al. | 2006
- S523
-
P.7.a.002 Use of levetiracetam in Aspergers Disorder patients: an open-label trialMech, A. W. et al. | 2006
- S524
-
P.7.a.004 The difference of IQ and behavioural problems among ADHD children showing modality-specific attention problemSon, J. W. / Lee, S. I. / Kim, S. K. / Shin, C. J. et al. | 2006
- S525
-
P.7.b.001 Prefrontal N-acetyl-aspartate and cognition in adolescents with first-episode psychosisZabala, A. / Sanchez, J. / Robles, O. / Moreno, D. / Burdalo, M. T. / Parellada, M. J. / Laita, P. / Desco, M. / Arango, C. et al. | 2006
- S526
-
P.7.c.001 Akathisia as frequent side effect of anaesthesia with neuroleptics in patients with attention deficit/hyperactivity disorderKrause, J. / Krause, K. H. et al. | 2006
- S527
-
P.7.c.003 Atomoxetine in the treatment of psychostimulant-naive children and adolescents with ADHD: a 6-week, randomized, placebo-controlled trial in RussiaMartenyi, F. / Zavadenko, N. / Jarkova, N. et al. | 2006
- S529
-
P.7.c.006 Antipsychotic drugs in children and adolescents: QTc interval elongationLaita, P. / Franco, C. / Llorente, C. / Cifuentes, A. / Ulloa, A. / Fraguas, D. / Arango, C. et al. | 2006
- S530
-
P.7.c.008 The clinical characteristics of the adolescent attention deficit/hyperactivity disorder (ADHD) patients and treatment effects of an extended-release preparation of methylphenidate (more large sample size than previous study)Oh, E. Y. et al. | 2006
- S531
-
P.7.d.001 Functional MRI of response inhibition in autismAnagnostou, E. / Fan, J. / Hollander, E. et al. | 2006
- S533
-
P.7.d.004 A preliminary study for standardization of the PSQ-K (paediatric sleep questionnaire -Korean version) in Korean childrenKweon, Y. S. / Jeun, W. H. / Lee, J. H. / Lee, H. K. / Lee, K. U. / Lee, J. T. et al. | 2006
- S534
-
P.7.e.002 Concentrations and glycosylations profile of acute phase proteins in anorexia nervosaKomorowska-Pietrzykowska, R. / Rajewski, A. / Sobieska, M. / Wiktorowicz, K. et al. | 2006
- S535
-
P.8.a.002 Quality of life in vitiligo and chronic urticaria patientsSukan, M. / Maner, F. et al. | 2006
- S536
-
P.8.a.004 Nocturnal eating episodes after taking zolpidem: are they sleep problems or eating problems?Kim, J. M. / Kim, Y. C. / Shin, H. B. / Lim, W. J. / Yun, K. W. / Paik, K. W. et al. | 2006
- S537
-
P.8.a.006 Can treatment of depression in primary care be improved with group counselling and patient education?Hansson, M. / Bodlund, O. et al. | 2006
- S538
-
P.8.a.008 The utility of structural neuroimaging in the psychiatric inpatientsPerez, M. P. / Prado, Y. P. / Paramo, M. P. et al. | 2006
- S539
-
P.8.a.010 Effects of galantamine on serum vitamin B12 and folic acid levels in patients with chronic fatigue immune dysfunction syndromeAsdemir, A. / Ozsoy, S. / Izgi, H. B. / Kula, M. / Deveci, M. / Yildiz, B. / Turan, T. / Esel, E. / Basturk, M. / Kirnap, M. et al. | 2006
- S541
-
P.8.a.014 Long-term evolution follow-up of patients treated with electroconvulsive therapyTajes, M. T. / Martinez, S. M. / Paramo, M. P. et al. | 2006
- S542
-
P.8.a.016 Impact of cerebrovascular accident on medical service resource utilization in a regional hospitalSicras Mainar, A. / Navarro Artieda, R. / Blanca Tamayo, M. / Llopart Lopez, J. R. / Serrat Tarres, J. / Rejas Gutierrez, J. et al. | 2006
- S544
-
P.8.a.019 Seasonally of cortisol secretionMorera, A. L. / Abreu, P. / Henry, M. / Garcia-Hernandez, A. / Guillen-Pino, F. / Gracia, R. et al. | 2006
- S545
-
P.8.a.021 Comparative acute efficacy and tolerability of OROS and immediate release formulations of methylphenidate in the treatment of adults with ADHDBiederman, J. / Spencer, T. J. / Mick, E. et al. | 2006
- S546
-
P.8.a.023 Lifetime comorbidity in bipolar disorder: bipolar subtype and gender differencesGrabski, B. / Dudek, D. / Datka, W. / Maczka, G. / Zieba, A. et al. | 2006
- S547
-
P.8.a.025 Testosterone levels in young male patients with affective disorder and schizophreniaRajewska-Rager, A. / Rajewska, J. / Kaminska, K. / Rybakowski, J. et al. | 2006
- S548
-
P.8.a.028 The role of gender in mixed mania: testing different definitions for mixed manic statesAldama, A. / Mosquera, F. / Gonzalez, C. / Ron, S. / Pecina, J. R. / Aspiazu, S. / Gonzalez-Pinto, A. et al. | 2006
- S551
-
P.8.a.033 Case-report of right unilateral anterior capsulotomy for obsessive-compulsive disorderDegraeve, G. / Audenaert, K. / Van Den Abbeele, D. / Van Heeringen, C. / Caemaert, J. / Van Roost, D. et al. | 2006
- S552
-
P.8.a.035 Lorazepam-induced reduction in activity mirrors decrements in cognitive and psychomotor performanceDawson, J. / Boyle, J. / Stanley, N. / Johnsen, S. / Hindmarch, I. / Skene, D. J. et al. | 2006
- S553
-
P.8.a.037 The Verona brain imaging study in schizophrenia: an integrated project with epidemiology and social psychiatryDusi, N. / Tansella, M. / Versace, A. / Andreone, N. / Rambaldelli, G. / Perlini, C. / Barbui, C. / Nose, M. / Cristofalo, D. / Gasparini, A. et al. | 2006
- S554
-
P.8.a.039 Driving ability in adults with attention-deficit hyperactivity disorder significantly improves when treated with methylphenidateVerster, J. C. / Bekker, E. M. / De Roos, M. / Minova, A. / Eijken, E. J. / Kooij, U. S. / Buitelaar, J. K. / Kenemans, J. L. / Verbaten, M. N. / Olivier, B. et al. | 2006
- S555
-
P.8.a.041 The correlation of dream recall and clinical variables in narcolepticsLee, S. P. / Jeong, J. H. / Hong, S. H. / Han, J. H. et al. | 2006
- S556
-
P.8.a.042 Persistent executive deficit in euthymic bipolar outpatients: a 2-year follow-up studyMur, M. / Portella, M. J. / Martinez-Aran, A. / Pifarre, J. / Vieta, E. et al. | 2006
- S557
-
P.8.a.044 Neuropsychological functioning in stabilised patients after a first psychotic episodeJimenez, A. / Gonzalez Gomez, C. / Palomino, A. / Dominguez, M. G. / Vega, P. / Gonzalez Oliveros, R. / Gonzalez-Pinto, A. et al. | 2006
- S558
-
P.8.a.046 Are zolpidem-induced amnesia and somnambulism rare incidences?Chen, C. C. / Yang, P. / Chung, W. L. / Chour1, W. Y. et al. | 2006
- S559
-
P.8.a.048 Childhood physical and sexual abuse in 100 nonviolent suicide attempters in BudapestRihmer, A. / Rozsa, S. / Rihmer, Z. et al. | 2006
- S560
-
P.8.a.050 Gender differences in mood spectrum: clinical aspectsCarlini, M. / Bevilacqua, L. / Rucci, P. / Baldini, A. / Carmassi, C. / Golia, F. / DellOsso, L. et al. | 2006
- S563
-
P.8.b.001 Prevalence rates of major mental disorders in mental health related facilities in KoreaCho, S. J. / Park, J. I. / Bae, J. N. / Hahm, B. J. / Lee, J. Y. / Cho, M. J. et al. | 2006
- S564
-
P.8.b.002 Acetylcholine-mediated regulation of secretory cells is associated with calcium release from endoplasmic reticulum via InsPS-sensitive ion channelsKopach, O. V. / Kruglikov, L. A. / Voitenko, N. V. / Fedirko, N. V. et al. | 2006
- S565
-
P.8.b.004 Synergetic effect of P1 and muscarinic receptors activation - new mechanism of autoregulation of submandibular salivary cells?Fedirko, N. V. / Kopach, O. V. / Kruglikov, L. A. / Voitenko, N. V. et al. | 2006
- S566
-
P.8.b.006 Involvement of a2-adrenoceptors in the local peripheral anti-hyperalgesic effect of carbamazepineTomic, M. / Vuckovic, S. / Stepanovic-Petrovic, R. / Ugresic, N. / Prostran, M. / Boskovic, B. et al. | 2006